Details of Disease

General Information of Disease (ID: DISKNDYU)

Disease Name Coronary atherosclerosis
Synonyms atherosclerosis of coronary artery; coronary artery arteriosclerosis disorder; coronary artery arteriosclerosis (disease); arteriosclerosis disorder of coronary artery; coronary atherosclerosis
Definition Atherosclerosis of the coronary vasculature.
Disease Hierarchy
DISMN9J3: Atherosclerosis
DIS5OIP1: Coronary heart disease
DISK5QGC: Arteriosclerosis
DISKNDYU: Coronary atherosclerosis
Disease Identifiers
MONDO ID
MONDO_0021661
MESH ID
D003324
UMLS CUI
C0010054
MedGen ID
3623
HPO ID
HP:0001677
SNOMED CT ID
443502000

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 2 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Atorvastatin DMF28YC Approved Small molecular drug [1]
Fenofibrate DMFKXDY Approved Small molecular drug [2]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 279 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
ACR TTAHE2N Limited Biomarker [3]
ADAM33 TTQICM2 Limited Genetic Variation [4]
ADAMTS1 TTS2TEI Limited Genetic Variation [5]
ADAMTS4 TTYG6BU Limited Biomarker [6]
ADORA1 TTK25J1 Limited Altered Expression [7]
ADORA3 TTJFY5U Limited Genetic Variation [8]
ADRA2A TTWG9A4 Limited Genetic Variation [9]
ADRA2B TTWM4TY Limited Biomarker [10]
ADRB3 TTMXGCW Limited Genetic Variation [11]
ALOX5AP TTDMBF5 Limited Genetic Variation [12]
ANGPTL3 TT59GO7 Limited Genetic Variation [13]
APOA2 TTGQA9W Limited Biomarker [14]
CCL17 TTMPHAE Limited Genetic Variation [15]
CCL5 TT9DWLC Limited Genetic Variation [16]
CD59 TTBGTEJ Limited Biomarker [17]
CES1 TTMF541 Limited Genetic Variation [18]
CPS1 TT42M75 Limited Biomarker [19]
CYP11B2 TT9MNE2 Limited Genetic Variation [20]
CYP2B6 TTMH124 Limited Genetic Variation [20]
CYP2C9 TTR40YJ Limited Genetic Variation [21]
CYP2J2 TTNE1C7 Limited Altered Expression [22]
CYP3A5 TTHS0OK Limited Genetic Variation [23]
ECE1 TTQ9RYT Limited Genetic Variation [24]
ENPP1 TTZTIWS Limited Genetic Variation [25]
F11R TT3C8EG Limited Genetic Variation [26]
F2R TTL935N Limited Altered Expression [27]
FCGR2B TT5RWKQ Limited Biomarker [28]
FGF21 TTQ916P Limited Altered Expression [29]
FGFR4 TT1KX2S Limited Genetic Variation [30]
GGT1 TTZVT7O Limited Altered Expression [31]
GLP2R TT1YWO5 Limited Biomarker [32]
GP6 TTTJUVZ Limited Altered Expression [33]
GRIK4 TTQV6BO Limited Biomarker [34]
GRK2 TTAZ3MN Limited Biomarker [35]
HDAC9 TT8M4E1 Limited Genetic Variation [36]
HMGB1 TTWQYB7 Limited Biomarker [37]
HNF1A TT01M3K Limited Genetic Variation [38]
HPSE TTR7GJO Limited Biomarker [39]
HSPA8 TTMQL3K Limited Genetic Variation [40]
IFNL3 TTRF4Q2 Limited Genetic Variation [41]
IL15RA TTGN89I Limited Biomarker [42]
IL16 TTW4R0B Limited Genetic Variation [43]
IL1RL1 TT4GZA4 Limited Biomarker [44]
IL23R TT6H4QR Limited Genetic Variation [45]
LAMP2 TTULDG7 Limited Altered Expression [46]
LBP TTVQJLY Limited Biomarker [47]
LIPA TTS8T1M Limited Biomarker [48]
LIPG TTHSZXO Limited Genetic Variation [49]
LRP6 TTSXOWE Limited Biomarker [50]
MIA TT5HNVS Limited Genetic Variation [51]
MVK TT5DFHW Limited Genetic Variation [52]
MYBPC3 TT9WOBN Limited Genetic Variation [53]
NFKB1 TTUIZKC Limited Genetic Variation [54]
NPFFR2 TTXYNDJ Limited Altered Expression [55]
NPPB TTY63XT Limited Biomarker [56]
NR3C2 TT26PHO Limited Biomarker [57]
P2RY12 TTZ1DT0 Limited Biomarker [58]
PCSK1 TTED9LZ Limited Genetic Variation [59]
PDE4D TTSKMI8 Limited Genetic Variation [60]
PDGFD TTSN0GA Limited Genetic Variation [61]
PIK3CB TT9H4P3 Limited Biomarker [62]
PPIA TTL2ADK Limited Altered Expression [63]
PRKCH TTONI0R Limited Genetic Variation [64]
RBP4 TT0C8BY Limited Biomarker [65]
SENP1 TTW9HY5 Limited Biomarker [66]
SLC22A3 TTG2UMS Limited Genetic Variation [67]
SMAD3 TTHQZV7 Limited Genetic Variation [68]
THRA TTTSEPU Limited Genetic Variation [69]
TLR8 TT8CWFK Limited Genetic Variation [70]
TMSB4X TTMVAIU Limited Genetic Variation [71]
TNFRSF11B TT2CJ75 Limited Altered Expression [72]
TNFRSF4 TTL31H0 Limited Biomarker [73]
TNFSF4 TTBW580 Limited Biomarker [74]
VKORC1 TTEUC8H Limited Genetic Variation [75]
ZNF217 TTY3BRA Limited Genetic Variation [76]
ACACB TTY84UG Disputed Genetic Variation [77]
ACAT1 TTK3C21 Disputed Genetic Variation [18]
CTH TTLQUZS Disputed Genetic Variation [78]
F11 TTDM4ZU Disputed Biomarker [79]
IFNGR2 TT13TL0 Disputed Biomarker [80]
ADORA2B TTNE7KG moderate Biomarker [81]
ANGPT1 TTWNQ1T moderate Altered Expression [82]
ARG2 TTV1AG6 moderate Posttranslational Modification [83]
ARRB2 TT8SO2I moderate Biomarker [84]
C5 TTKANGO moderate Biomarker [85]
CA2 TTANPDJ moderate Biomarker [86]
CCR5 TTJIH8Q moderate Genetic Variation [87]
CX3CR1 TT2T98G moderate Genetic Variation [87]
DDIT4 TTVEOY6 moderate Biomarker [88]
EIF5A TTIVCNR moderate Altered Expression [89]
ESR2 TTOM3J0 moderate Biomarker [90]
FABP4 TTHWMFZ moderate Altered Expression [91]
FUT3 TTUPAD7 moderate Genetic Variation [92]
GCH1 TTLSWP6 moderate Genetic Variation [93]
GLP1R TTVIMDE moderate Biomarker [94]
HCAR2 TTWNV8U moderate Biomarker [95]
IL17A TTG0MT6 moderate Genetic Variation [45]
IL1RN TT6GSR3 moderate Biomarker [96]
IRAK1 TTXAJWN moderate Biomarker [97]
KCNQ3 TTIVDM3 moderate Altered Expression [98]
KLK4 TT4319X moderate Biomarker [99]
LEP TTBJEZ5 moderate Genetic Variation [100]
LOX TTQHNAM moderate Genetic Variation [101]
MAS1 TTOISYB moderate Biomarker [82]
NOD1 TTYSRXM moderate Genetic Variation [102]
P2RX3 TT2THBD moderate Biomarker [103]
P2RX4 TT1NLOA moderate Altered Expression [104]
P2RY11 TTYXPCO moderate Biomarker [105]
PLN TTMCVJF moderate Biomarker [106]
PPARA TTJ584C moderate Genetic Variation [107]
PROC TTZUXYS moderate Genetic Variation [108]
RAB9A TT958S6 moderate Genetic Variation [109]
S100G TTIXUDE moderate Biomarker [110]
SCN9A TT4G2JS moderate Altered Expression [98]
SLC26A4 TT7X02I moderate Genetic Variation [111]
SLC9A1 TTGSEFH moderate Altered Expression [112]
ST8SIA4 TTDP8YM moderate Genetic Variation [113]
TAGLN TTDRZ9H moderate Biomarker [114]
TRPC3 TTNVC34 moderate Biomarker [115]
VDAC1 TTAMKGB moderate Biomarker [116]
VDR TTK59TV moderate Genetic Variation [117]
ABCC9 TTEF5MJ Strong Biomarker [118]
ABCG1 TTMWDGU Strong Genetic Variation [119]
ABCG5 TTKZ7WY Strong Genetic Variation [120]
ACE2 TTUI5H7 Strong Altered Expression [82]
ADA TTLP57V Strong Altered Expression [121]
ADAM8 TTQWYMD Strong Genetic Variation [122]
ADAMTS13 TTUREBK Strong Biomarker [123]
ADRA1D TT34BHT Strong Biomarker [124]
ADRB1 TTR6W5O Strong Biomarker [125]
AHSG TTKF4WV Strong Altered Expression [126]
AKR1B1 TTFBNVI Strong Altered Expression [127]
ALOX15 TTN9T81 Strong Genetic Variation [128]
ALOX5 TTSJ6Q4 Strong Biomarker [129]
ALPL TTMR5UV Strong Altered Expression [130]
ANGPT2 TTKLQTJ Strong Biomarker [131]
ANGPTL4 TTWALY5 Strong Genetic Variation [132]
APCS TTB7VAT Strong Biomarker [133]
APLN TT87D3J Strong Altered Expression [134]
APOA4 TTNC3WS Strong Genetic Variation [135]
APOC3 TTXOZQ1 Strong Biomarker [136]
ARSA TTYQANR Strong Genetic Variation [137]
ASGR1 TTYM94H Strong Genetic Variation [138]
ASIC3 TTLGDIS Strong Biomarker [139]
BCHE TT3MSAO Strong Altered Expression [140]
CACNA1C TTZIFHC Strong Genetic Variation [141]
CAD TT2YT1K Strong Biomarker [142]
CBS TTVZJ7G Strong Genetic Variation [143]
CCN1 TTPK79J Strong Biomarker [144]
CCR9 TTIPS8B Strong Biomarker [145]
CD40LG TTIJP3Q Strong Biomarker [146]
CDK18 TTUMFAR Strong Genetic Variation [147]
CPB2 TTP18AY Strong Genetic Variation [148]
CPE TTXPWO6 Strong Genetic Variation [149]
CR1 TTEA8OW Strong Genetic Variation [150]
CTSS TTUMQVO Strong Biomarker [151]
CXCL12 TT4UGTF Strong Genetic Variation [152]
CYP17A1 TTRA5BZ Strong Genetic Variation [153]
CYP2D6 TTVG215 Strong Genetic Variation [154]
CYP3A4 TTWP7HQ Strong Biomarker [155]
CYSLTR1 TTGKOY9 Strong Biomarker [156]
EHMT1 TTOFXD7 Strong Biomarker [157]
EIF2AK4 TT9U4EP Strong Altered Expression [158]
EPHX2 TT7WVHI Strong Genetic Variation [159]
EPO TTQG4NR Strong Biomarker [160]
F10 TTCIHJA Strong Altered Expression [161]
F12 TTRJSMV Strong Genetic Variation [162]
F2RL3 TTD0652 Strong Posttranslational Modification [163]
F3 TT38MDJ Strong Biomarker [164]
F5 TT1O264 Strong Biomarker [165]
F7 TTF0EGX Strong Genetic Variation [166]
F8 TT1290U Strong Altered Expression [167]
FABP3 TT3TGLR Strong Biomarker [168]
FADS2 TTT2VDU Strong Genetic Variation [169]
FCGR2A TTXT21W Strong Biomarker [170]
FCGR3A TTIFOC0 Strong Biomarker [171]
FDPS TTIKWV4 Strong Biomarker [172]
FGF4 TTCEKVZ Strong Biomarker [173]
FTO TTFW3BT Strong Genetic Variation [174]
GCG TT6Y4PN Strong Biomarker [157]
GCK TTDLNGZ Strong Genetic Variation [175]
GDF15 TT4MXVG Strong Biomarker [176]
GJA4 TTQO1VY Strong Biomarker [177]
GLO1 TTV9A7R Strong Altered Expression [178]
GP1BA TTVB0Q9 Strong Genetic Variation [179]
GPX1 TTYAHBP Strong Biomarker [180]
HBA2 TTQO71U Strong Biomarker [181]
HMGCR TTPADOQ Strong Biomarker [182]
HSPB3 TTLH8WG Strong Biomarker [183]
HSPD1 TT9HL5R Strong Altered Expression [184]
IL37 TTQTX98 Strong Biomarker [185]
IRS1 TTAJSQ0 Strong Altered Expression [186]
ITGB3 TTJA1ZO Strong Biomarker [187]
KDM3A TTKXS4A Strong Biomarker [188]
KLK1 TT5T3P6 Strong Biomarker [189]
KNG1 TTDJ4MY Strong Biomarker [190]
LCAT TTGZ91P Strong Genetic Variation [191]
LCN2 TTKTLAI Strong Biomarker [192]
LEPR TT0HD6V Strong Genetic Variation [100]
MC4R TTD0CIQ Strong Genetic Variation [193]
MFGE8 TT1GLAJ Strong Biomarker [194]
MGAM TTXWASR Strong Biomarker [195]
MMP1 TTMX39J Strong Genetic Variation [196]
MMP12 TTXZ0KQ Strong Genetic Variation [197]
MMP8 TTGA1IV Strong Biomarker [198]
MTR TTUTO39 Strong Genetic Variation [199]
MTTP TTUS1RD Strong Genetic Variation [200]
MUSK TT6SA0X Strong Genetic Variation [201]
NAMPT TTD1WIG Strong Genetic Variation [202]
NPC1L1 TTPD1CN Strong Altered Expression [203]
NPR3 TTWVLS6 Strong Genetic Variation [204]
NPY TT64REZ Strong Biomarker [205]
NRG4 TTWAGKJ Strong Biomarker [206]
NTN1 TT0AH4L Strong Biomarker [207]
OTC TT5KIO9 Strong Biomarker [208]
P2RY1 TTA93TL Strong Genetic Variation [209]
PDE3B TTN34SQ Strong Genetic Variation [210]
PECAM1 TT4EZB2 Strong Biomarker [211]
PLA2G7 TTDNFMT Strong Biomarker [212]
PLG TTP86E2 Strong Biomarker [213]
PLTP TTZF6SN Strong Altered Expression [214]
PPARD TT2JWF6 Strong Altered Expression [215]
PPID TTNAFOU Strong Biomarker [216]
PPIF TTRFQTB Strong Biomarker [216]
PRKCE TT57MT2 Strong Altered Expression [217]
PTGS2 TTVKILB Strong Altered Expression [218]
SAA1 TTY0DN9 Strong Biomarker [114]
SCARB1 TTRE324 Strong Genetic Variation [219]
SCD TT6RIOV Strong Genetic Variation [201]
SCN5A TTZOVE0 Strong Biomarker [220]
SELL TT2IYXF Strong Biomarker [221]
SELP TTE5VG0 Strong Genetic Variation [222]
SERPINF1 TTR59S1 Strong Biomarker [223]
SERPINH1 TTPSWQG Strong Biomarker [224]
SFRP4 TTX8I1Y Strong Biomarker [225]
SH2B3 TT36N7Z Strong Genetic Variation [226]
SLC22A6 TTTYH7A Strong Biomarker [227]
SLC22A8 TTTQR47 Strong Biomarker [227]
SLC2A9 TTIF3GB Strong Genetic Variation [228]
SLC33A1 TTL69WB Strong Biomarker [189]
SLC5A1 TT2UE56 Strong Biomarker [229]
SLC5A2 TTF8JAT Strong Biomarker [94]
SLCO1B1 TTFGXEB Strong Genetic Variation [230]
SOAT2 TTAK0IN Strong Genetic Variation [231]
SORT1 TTRX9AV Strong Biomarker [232]
SREBF1 TTER0UB Strong Biomarker [233]
SREBF2 TTRQ4AP Strong Genetic Variation [233]
SRGN TTCHB06 Strong Altered Expression [234]
TCF7L2 TT80QAL Strong Altered Expression [50]
TERF1 TT1Y6J2 Strong Altered Expression [235]
TERT TTQY2EJ Strong Genetic Variation [236]
TFPI TT068JH Strong Genetic Variation [237]
THPO TTCG5PE Strong Biomarker [238]
TNC TTUCPMY Strong Biomarker [239]
TNFRSF1B TT63WSF Strong Biomarker [240]
TNFSF14 TTKVENM Strong Biomarker [241]
TNNI3 TTNLDK6 Strong Altered Expression [242]
TPSD1 TTNWD8O Strong Biomarker [243]
TRAF6 TTCDR6M Strong Biomarker [244]
TXN TTZJ5U9 Strong Biomarker [245]
TXNIP TTTLDZK Strong Biomarker [246]
UCP1 TTI12YJ Strong Altered Expression [247]
UCP2 TTSC2YM Strong Biomarker [248]
UTS2 TTERU0T Strong Altered Expression [249]
UTS2R TTW5UDX Strong Altered Expression [250]
VEGFB TTPJQHE Strong Biomarker [251]
VEGFC TT0QUFV Strong Genetic Variation [252]
YOD1 TTFSH0K Strong Biomarker [253]
C3AR1 TTI6B3F Definitive Biomarker [254]
CEL TTTRNQW Definitive Biomarker [255]
CRLF2 TTRMZ0N Definitive Biomarker [256]
FCGR1A TTZK4I3 Definitive Altered Expression [257]
FGF19 TTGCH11 Definitive Biomarker [258]
HMGB2 TTA78JQ Definitive Altered Expression [259]
POR TTOQ9GZ Definitive Altered Expression [260]
PTAFR TTQL5VC Definitive Genetic Variation [261]
SETD7 TTJ0FSU Definitive Biomarker [262]
SUV39H1 TTUWQTK Definitive Biomarker [262]
TNFRSF13C TT7NJSE Definitive Biomarker [263]
------------------------------------------------------------------------------------
⏷ Show the Full List of 279 DTT(s)
This Disease Is Related to 5 DTP Molecule(s)
Gene Name DTP ID Evidence Level Mode of Inheritance REF
SLC2A6 DTS4MKQ Limited Genetic Variation [264]
SLC7A13 DTMWE5P Limited Biomarker [265]
SLC25A20 DTQOUM4 moderate Biomarker [86]
ABCC6 DT582KR Strong Biomarker [266]
ATP2B1 DTJWQ1L Strong Biomarker [267]
------------------------------------------------------------------------------------
This Disease Is Related to 28 DME Molecule(s)
Gene Name DME ID Evidence Level Mode of Inheritance REF
ADH1C DEM1HNL Limited Genetic Variation [268]
CYP27A1 DEBS639 Limited Genetic Variation [269]
CYP2C18 DEZMWRE Limited Genetic Variation [270]
DDAH1 DEY0TQC Limited Genetic Variation [271]
FADS1 DE05S8C Limited Genetic Variation [201]
MSRA DEU2ZBY Limited Genetic Variation [272]
CYP1A1 DE6OQ3W moderate Biomarker [273]
PON2 DEHJU7E moderate Biomarker [274]
PON3 DETXQZ1 moderate Biomarker [275]
ACSS2 DEE76VW Strong Genetic Variation [276]
AS3MT DE9KJP3 Strong Genetic Variation [277]
BCO1 DE6BOK3 Strong Genetic Variation [278]
CPA4 DEXKD7J Strong Biomarker [279]
CYP2R1 DEBIHM3 Strong Genetic Variation [280]
CYP4A11 DE2XQGW Strong Genetic Variation [281]
CYP4F2 DE3GT9C Strong Genetic Variation [282]
CYP7A1 DEDZRQ1 Strong Genetic Variation [283]
DHCR7 DEL7GFA Strong Genetic Variation [284]
GCLC DESYL1F Strong Biomarker [285]
GSTM1 DEYZEJA Strong Genetic Variation [286]
MTARC2 DE6QH2D Strong Biomarker [287]
NADSYN1 DELF8BA Strong Genetic Variation [284]
NAT2 DER7TA0 Strong Genetic Variation [288]
NNMT DECVGJ3 Strong Genetic Variation [289]
PCYT1A DEQYXD4 Strong Biomarker [290]
SI DE5EO4Y Strong Biomarker [195]
UGT1A6 DESD26P Strong Genetic Variation [291]
ACP5 DESITDW Definitive Biomarker [292]
------------------------------------------------------------------------------------
⏷ Show the Full List of 28 DME(s)
This Disease Is Related to 337 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
ABRAXAS2 OTAW1I4C Limited Altered Expression [293]
ACKR2 OTWYY14H Limited Biomarker [294]
ADAR OTQNOHR8 Limited Altered Expression [295]
ADIPOR1 OT65ZFZN Limited Altered Expression [296]
AGXT2 OTO6QUTM Limited Genetic Variation [271]
AIDA OTMRLWGT Limited Biomarker [297]
ALOX15B OTWQQ08W Limited Genetic Variation [298]
ANGPTL2 OTB6JG41 Limited Biomarker [299]
ANP32B OT3SQMLU Limited Altered Expression [27]
APOC1 OTA58CED Limited Genetic Variation [300]
APOD OTT77XW8 Limited Biomarker [301]
APPL1 OT8VR95S Limited Genetic Variation [302]
ARID5B OTUQ4CQY Limited Genetic Variation [303]
BCAR1 OTKT2C2N Limited Genetic Variation [304]
BGLAP OTK1YLWQ Limited Biomarker [305]
BHMT OTYB6PXZ Limited Genetic Variation [306]
BRINP3 OT4VFHWN Limited Genetic Variation [307]
BTN2A1 OTUYPMZJ Limited Genetic Variation [308]
BUD13 OTXG6MX5 Limited Genetic Variation [309]
C12orf43 OTQXALOA Limited Genetic Variation [310]
C1QL3 OT4TZH3J Limited Altered Expression [311]
CAP1 OTYM8A2N Limited Biomarker [312]
CCDC92 OT1YHLOR Limited Biomarker [313]
CCL19 OTQ2UJMH Limited Biomarker [314]
CD93 OT6HZT6H Limited Biomarker [315]
CFDP1 OTXY7J96 Limited Genetic Variation [304]
CHI3L1 OT2Z7VJH Limited Altered Expression [316]
CMTM5 OTMS7NDP Limited Biomarker [317]
CNBP OTTGM9NK Limited Genetic Variation [318]
COMP OTS2FPMI Limited Altered Expression [319]
CORT OTX3GUHB Limited Biomarker [320]
CREG1 OTRHJ8HK Limited Genetic Variation [321]
CXCL5 OTZOUPCA Limited Biomarker [322]
DUOX1 OTQ2AEW0 Limited Genetic Variation [323]
DUOX2 OTU14HCN Limited Genetic Variation [323]
EBF1 OTZ61YYH Limited Genetic Variation [324]
EGR3 OTGPJIRA Limited Genetic Variation [325]
ELMO1 OTY2ORXK Limited Biomarker [326]
ENHO OT91QASK Limited Biomarker [327]
ESYT3 OTG5H3YF Limited Genetic Variation [328]
FCGR2C OTNLMNYB Limited Biomarker [28]
FEN1 OT6QGG7O Limited Genetic Variation [329]
FLOT2 OTZ0QR5L Limited Biomarker [330]
GDF10 OTEVXGJ7 Limited Genetic Variation [331]
GPD1L OTVLWW9T Limited Genetic Variation [332]
GPR162 OTK4LT3K Limited Biomarker [333]
GPX3 OT6PK94R Limited Genetic Variation [334]
GRK4 OTUU8V2S Limited Genetic Variation [335]
GSTM2 OTG4WT05 Limited Genetic Variation [336]
GUCY1A1 OTPTCBUN Limited Genetic Variation [337]
HAND2 OTCXYW4Y Limited Genetic Variation [338]
HPSE2 OTGEPP8V Limited Biomarker [339]
HSPA2 OTSDET7B Limited Biomarker [340]
IRF2BP2 OTSSRRCA Limited Altered Expression [341]
ITLN1 OT7ZLJVV Limited Altered Expression [342]
KCTD10 OT5HFZXU Limited Genetic Variation [343]
KIDINS220 OTLBH2MA Limited Genetic Variation [344]
KIF2B OTLPAX4N Limited Genetic Variation [345]
KLF15 OTGMQMVR Limited Altered Expression [346]
KLF2 OTIP1UFX Limited Genetic Variation [341]
LGALS3BP OT9AGQKH Limited Biomarker [347]
LMAN1 OTYHKDEO Limited Genetic Variation [348]
LRP8 OTZ71YV2 Limited Genetic Variation [349]
MADD OTUFYVGG Limited Genetic Variation [350]
MAFB OTH2N3T8 Limited Genetic Variation [351]
MCFD2 OTM0XU0U Limited Genetic Variation [348]
MPHOSPH6 OT6E2S48 Limited Genetic Variation [352]
MYLIP OTL0PFGV Limited Genetic Variation [353]
NDST4 OTEKG7JJ Limited Genetic Variation [354]
NDUFAB1 OTF906UR Limited Genetic Variation [355]
NEXN OTKB0B0H Limited Altered Expression [356]
NHS OTKE8QAT Limited Biomarker [357]
NOX5 OTHTH59G Limited Biomarker [358]
NUDT1 OTZSES3W Limited Genetic Variation [359]
PCLAF OTMVIOUU Limited Genetic Variation [360]
PER2 OTU2B1DJ Limited Biomarker [361]
PF4V1 OT2CXM6L Limited Biomarker [362]
PLA2G10 OTRZ2L5A Limited Altered Expression [363]
PLA2G2D OTU604XM Limited Biomarker [364]
PRDM10 OTDDWU5Q Limited Genetic Variation [365]
PRORP OTWIS44P Limited Genetic Variation [366]
QRSL1 OTJDU2UG Limited Genetic Variation [294]
RPN1 OTEG4KU9 Limited Biomarker [294]
SCAI OTAK3TMO Limited Genetic Variation [367]
SERPINA12 OTS1E6IP Limited Genetic Variation [368]
SERPINB2 OT72QLZB Limited Genetic Variation [369]
SERPINB9 OTJ811IF Limited Biomarker [370]
SHBG OTPWU5IW Limited Biomarker [371]
SIGLEC1 OTNWSQA9 Limited Biomarker [372]
SIRT4 OT5S0J23 Limited Altered Expression [373]
SOD3 OTIOZQAB Limited Genetic Variation [374]
SPESP1 OTWXKKTJ Limited Genetic Variation [87]
ST6GALNAC5 OTH91ETM Limited Genetic Variation [375]
STN1 OT8UWRA3 Limited Genetic Variation [376]
SUMO4 OT9B447E Limited Genetic Variation [377]
TBX5 OT70PISV Limited Genetic Variation [338]
TCN2 OT41D0L3 Limited Genetic Variation [378]
TES OTL8PP6V Limited Biomarker [379]
TFAP2B OTR1T8E9 Limited Altered Expression [380]
TIMP4 OT8A68SW Limited Genetic Variation [381]
TMEM170A OT65DTBD Limited Genetic Variation [304]
TNNT1 OT8PBOAR Limited Genetic Variation [382]
TRAF5 OTSBTLO0 Limited Altered Expression [383]
TRIB3 OTG5OS7X Limited Genetic Variation [384]
CCHCR1 OT22C116 Disputed Biomarker [371]
EFNA5 OTOH4DRR Disputed Biomarker [80]
ERLIN1 OTUOOODY Disputed Genetic Variation [77]
FETUB OT7V07NI Disputed Biomarker [385]
PSMD4 OTH1VZTM Disputed Biomarker [80]
RFX1 OTZUDMPR Disputed Altered Expression [386]
SELENBP1 OT3NZNTR Disputed Biomarker [371]
STARD7 OTDUZ296 Disputed Biomarker [10]
TNFRSF6B OTKAN9G7 Disputed Biomarker [62]
ABCG8 OTIJ76XW moderate Genetic Variation [387]
ACP1 OTJ9CKLU moderate Genetic Variation [388]
ADA2 OTGCV24S moderate Genetic Variation [389]
AQP5 OT77GBY8 moderate Altered Expression [390]
ARL2BP OT7REEDA moderate Genetic Variation [391]
ATP4B OTIP2EYJ moderate Biomarker [95]
ATXN2L OTP5M3R9 moderate Altered Expression [392]
BSND OTYWZWPD moderate Genetic Variation [391]
CAPN10 OTS9LJW4 moderate Biomarker [393]
CHD1L OT7CZK7C moderate Altered Expression [394]
CIRBP OTXWTPBL moderate Biomarker [395]
CLEC7A OTRTBH27 moderate Biomarker [396]
DESI1 OTFNIW98 moderate Biomarker [397]
DIAPH1 OTZBYPLH moderate Biomarker [398]
EARS2 OTNCJKY7 moderate Biomarker [399]
EEF2 OTZ7SZ39 moderate Biomarker [400]
EHD3 OTOKC2G5 moderate Genetic Variation [401]
ENDOG OT5IM7B3 moderate Biomarker [402]
FBN1 OTYCJT63 moderate Genetic Variation [403]
FUNDC1 OTA6IVKQ moderate Biomarker [404]
FXYD1 OTNKT6GP moderate Altered Expression [405]
GALNT2 OTZZ5386 moderate Posttranslational Modification [406]
GGPS1 OTVEHG28 moderate Biomarker [407]
HEATR6 OTD3MYS0 moderate Genetic Variation [408]
HECTD1 OTJ95JJS moderate Biomarker [409]
INSIG1 OTZF5X1D moderate Genetic Variation [410]
INSIG2 OTX4VY51 moderate Genetic Variation [410]
JAZF1 OTXTYSYD moderate Altered Expression [411]
KLF10 OT4F4UGS moderate Biomarker [412]
LPCAT3 OTWI96P4 moderate Biomarker [413]
MB OTYWYL2D moderate Biomarker [414]
MCF2L2 OTOGFMIH moderate Biomarker [415]
MCU OTQZAYWQ moderate Biomarker [416]
MPRIP OT5FV5NS moderate Biomarker [417]
MPZL2 OTKFNDUI moderate Genetic Variation [111]
MSX2 OT1WDKE1 moderate Biomarker [418]
PARL OT7DMHSA moderate Genetic Variation [419]
PHLPP1 OTIFXW8D moderate Altered Expression [420]
PIAS1 OTZVAHZI moderate Biomarker [421]
PLIN5 OTV8G50L moderate Biomarker [422]
PPAN OT0UFQBZ moderate Biomarker [105]
PROCR OTRHED17 moderate Biomarker [423]
RARRES2 OT1BJE8K moderate Biomarker [424]
RCAN1 OT1MVXC7 moderate Altered Expression [425]
RMDN3 OTKO7AUM moderate Biomarker [426]
RPA1 OT76POLP moderate Genetic Variation [427]
SAA2 OTYAVJWG moderate Biomarker [114]
SELENOS OTUEWIU9 moderate Genetic Variation [428]
SENP3 OTFQDOMC moderate Biomarker [429]
SLC35G1 OTKZUA8O moderate Biomarker [397]
TAB1 OTPM6F85 moderate Genetic Variation [430]
TADA2A OTXUMEL9 moderate Genetic Variation [389]
TBL1Y OTA0F7TM moderate Genetic Variation [431]
TRAF1 OTTLM5RU moderate Biomarker [432]
TRIM63 OTUSWA74 moderate Altered Expression [433]
ACADS OTGFANYQ Strong Biomarker [434]
ACAT2 OTZ092ZJ Strong Biomarker [435]
ACCS OTHIHI9D Strong Genetic Variation [276]
ACTA2 OTEDLG8E Strong Genetic Variation [436]
ADD1 OTTF68DC Strong Genetic Variation [437]
ADIPOR2 OT2HDTL8 Strong Altered Expression [438]
ADTRP OTFI2BQX Strong Biomarker [439]
AMFR OTQRX7LC Strong Genetic Variation [440]
AMPD1 OTU17BCI Strong Genetic Variation [441]
ANGPTL8 OTQFINCD Strong Altered Expression [442]
ANKS1A OTYZP3MP Strong Genetic Variation [147]
AP1S2 OTZHJFYI Strong Biomarker [443]
APOM OTI3FQQC Strong Genetic Variation [444]
ARC OTN2QQPG Strong Altered Expression [445]
ARL15 OT00YSWZ Strong Genetic Variation [446]
ARPP21 OTWXZN5I Strong Biomarker [447]
BTBD8 OT3A3RD7 Strong Genetic Variation [448]
BTNL2 OTTTEMZA Strong Biomarker [449]
C16orf82 OT77Z5Y5 Strong Genetic Variation [382]
C1QTNF1 OT7I7KHC Strong Altered Expression [450]
C1QTNF12 OTFAIQHR Strong Altered Expression [451]
C1QTNF9 OTLI3VA3 Strong Biomarker [452]
C5AR2 OTP1Q82J Strong Genetic Variation [453]
CAMK2N1 OTKCR5XL Strong Altered Expression [454]
CAPG OTJ86KI6 Strong Biomarker [455]
CASQ2 OT09MNQ8 Strong Genetic Variation [456]
CDKN2B OTAG24N1 Strong Genetic Variation [457]
CELSR2 OTON6JSZ Strong Altered Expression [458]
CLEC1B OTO38TRG Strong Biomarker [459]
CNNM2 OTZHO8WU Strong Genetic Variation [152]
COL4A1 OTL6D1YE Strong Genetic Variation [460]
COX8A OTU0NR39 Strong Biomarker [461]
CPA3 OTOK8M0V Strong Biomarker [279]
CSN2 OT22C0PD Strong Biomarker [462]
CTRB1 OTFFF738 Strong Genetic Variation [463]
DAB2IP OTF456VC Strong Genetic Variation [464]
DBP OTE0W7LN Strong Biomarker [465]
DDAH2 OT8Q40G2 Strong Genetic Variation [466]
DECR1 OTCDIR6X Strong Biomarker [467]
DOCK7 OTINNVQV Strong Genetic Variation [468]
EDIL3 OTDVVNS0 Strong Biomarker [469]
EPRS1 OTXK0FLB Strong Biomarker [470]
ERFE OTSES1HA Strong Altered Expression [471]
ESM1 OT331Y8V Strong Altered Expression [472]
FCAMR OTRPQ0SJ Strong Genetic Variation [473]
FCGR3B OTSLSPZG Strong Biomarker [171]
FLAD1 OTY8R02L Strong Genetic Variation [201]
GALNT4 OT6WKC13 Strong Genetic Variation [474]
GC OTWS63BY Strong Genetic Variation [475]
GCA OTAJ7ZHG Strong Biomarker [285]
GCKR OTSIWXGG Strong Biomarker [476]
GMCL1 OTRZHUFV Strong Biomarker [285]
GMFG OTMPNSE7 Strong Altered Expression [477]
GNB3 OTA6HYBA Strong Genetic Variation [478]
GPIHBP1 OTDF8R2M Strong Biomarker [479]
GPLD1 OTUUQOVY Strong Biomarker [480]
HHIPL1 OT3GMU2X Strong Biomarker [481]
HSPA14 OTZCA5LK Strong Genetic Variation [482]
HSPA1A OTKGIE76 Strong Biomarker [340]
HSPB2 OTS01646 Strong Biomarker [183]
IFRD1 OT4SQMLQ Strong Genetic Variation [483]
IGFBP4 OT2HZRBD Strong Biomarker [484]
IL17RA OTVVI8ER Strong Biomarker [485]
IL18BP OTW0LRYZ Strong Altered Expression [486]
IL34 OTZ15VVK Strong Biomarker [487]
IL6R OTCQL07Z Strong Genetic Variation [488]
ISYNA1 OT49ONSE Strong Biomarker [489]
ITGA2B OT4Y17PY Strong Genetic Variation [490]
JCAD OT7G1WJW Strong Genetic Variation [491]
JPH3 OTHTJO2I Strong Genetic Variation [492]
KALRN OT8WRCBH Strong Biomarker [493]
KCNJ8 OTZ8G8FE Strong Biomarker [494]
KIF2C OTJ8G3NP Strong Genetic Variation [495]
KIF6 OTDH3MR4 Strong Genetic Variation [496]
KL OTD4VWU6 Strong Altered Expression [497]
KLF14 OT8BXLBS Strong Biomarker [498]
KLLN OTV3FPH0 Strong Biomarker [499]
KRT1 OTIOJWA4 Strong Biomarker [500]
LDB2 OT6Y8IEK Strong Biomarker [501]
LIPC OTZY5SC9 Strong Genetic Variation [502]
LMOD1 OTZ2MEMG Strong Genetic Variation [503]
LTBP1 OTR7Q75L Strong Altered Expression [504]
MAP1LC3A OTPMGIU4 Strong Biomarker [505]
MAP3K7CL OT9J7RLC Strong Genetic Variation [506]
MEPE OTXJRUW0 Strong Genetic Variation [507]
METRN OTI2645G Strong Altered Expression [508]
METRNL OTB0DDL0 Strong Altered Expression [508]
MIA3 OTBVIZQD Strong Biomarker [439]
MLXIPL OTR9MLLW Strong Genetic Variation [509]
MMP23B OT2OR6TS Strong Biomarker [510]
MMRN1 OT7ZNYHT Strong Genetic Variation [511]
MON2 OTCSVMAR Strong Biomarker [512]
MPI OTBH6ZK1 Strong Biomarker [513]
MRTFA OTCVXASM Strong Genetic Variation [514]
NANOS3 OTGX9IQU Strong Genetic Variation [515]
NBL1 OTT37U4O Strong Biomarker [516]
NFKBIZ OTU728KS Strong Genetic Variation [517]
NLN OTFRITPU Strong Altered Expression [518]
NLRP12 OTGR132Z Strong Genetic Variation [519]
NMU OTW9X7BQ Strong Altered Expression [520]
NOS1AP OTDFOBRU Strong Genetic Variation [521]
NPC1 OTRIPICX Strong Genetic Variation [522]
NUCB2 OTHO6JWN Strong Altered Expression [523]
OPN4 OT1LZ7TS Strong Altered Expression [518]
OXCT1 OT536PE7 Strong Genetic Variation [524]
PADI2 OTT40K94 Strong Biomarker [525]
PAPPA OTTTG9PG Strong Genetic Variation [526]
PDCD4 OTZ6NXUX Strong Biomarker [527]
PEAR1 OT2XLTB2 Strong Genetic Variation [528]
PHACTR1 OTAMPX9V Strong Genetic Variation [529]
PIGR OT6GLSUL Strong Genetic Variation [473]
PIK3C2A OTFBU4GD Strong Altered Expression [530]
PIMREG OTKC8T3E Strong Altered Expression [531]
PKP2 OTJOVF68 Strong Biomarker [532]
PLA2G15 OT6VJTPA Strong Genetic Variation [276]
PLA2G5 OTQRSKCZ Strong Altered Expression [533]
PLAAT1 OTM3M6P4 Strong Biomarker [534]
PLB1 OTZ6TTYV Strong Biomarker [535]
PLPP3 OTSSF7BK Strong Genetic Variation [536]
POC1A OTXAG4PL Strong Genetic Variation [537]
PPARGC1A OTHCDQ22 Strong Altered Expression [538]
PPBP OT1FHGQS Strong Biomarker [539]
PPIC OTY5Q42N Strong Altered Expression [540]
PPM1B OTZMH6V3 Strong Biomarker [541]
PPP1R15A OTYG179K Strong Altered Expression [542]
PSMA6 OTJ6RPX5 Strong Genetic Variation [543]
PSRC1 OT7MDJMN Strong Altered Expression [544]
PTPRA OTZA82J1 Strong Genetic Variation [545]
PTX3 OTPXHRKU Strong Biomarker [546]
RAPSN OTGMSWDQ Strong Genetic Variation [201]
RELB OTU3QYEF Strong Biomarker [547]
RETN OTW5Z1NH Strong Biomarker [548]
RLN1 OTL6QNHG Strong Altered Expression [549]
RLN2 OTY3OG71 Strong Biomarker [550]
RNLS OTVP2WJM Strong Genetic Variation [551]
RYR2 OT0PF19E Strong Genetic Variation [456]
RYR3 OT4EHIP4 Strong Genetic Variation [552]
SCG2 OTXWUQQL Strong Biomarker [553]
SERPINE2 OTYF5340 Strong Biomarker [554]
SLN OTERIU75 Strong Altered Expression [555]
SNRNP70 OTP52YZ3 Strong Genetic Variation [556]
SOSTDC1 OTAKDNSM Strong Genetic Variation [557]
SP6 OTRAB1PN Strong Biomarker [498]
SPAAR OTWXG2R8 Strong Altered Expression [558]
TCP1 OT1MGUX9 Strong Biomarker [290]
TFEB OTJUJJQY Strong Biomarker [559]
TFR2 OTMYCCEO Strong Genetic Variation [560]
TREML4 OT2VLMTL Strong Altered Expression [561]
TRIB1 OTPEO17G Strong Altered Expression [562]
TRPS1 OT7XPPEL Strong Genetic Variation [562]
AP2A2 OTD1UGUN Definitive Genetic Variation [563]
C1QTNF3 OTOJMWW0 Definitive Biomarker [564]
CKMT2 OT1KNPI1 Definitive Biomarker [565]
CRISPLD1 OT38HXJP Definitive Genetic Variation [566]
DCLRE1C OTW3KB1I Definitive Biomarker [567]
DEFA1 OT5N1B9B Definitive Biomarker [568]
DEFA3 OTO3N8E1 Definitive Biomarker [568]
GALNT3 OT7M67WT Definitive Genetic Variation [569]
GOLGA6A OTHU9MRX Definitive Genetic Variation [570]
HABP2 OTAUIPW0 Definitive Genetic Variation [571]
INTS4 OT5JQ913 Definitive Biomarker [572]
IRF6 OTKJ44EV Definitive Genetic Variation [573]
LRRC3B OT9VDGPR Definitive Biomarker [565]
MRAS OTNCVCQW Definitive Biomarker [574]
MRPS6 OTKFY73U Definitive Biomarker [574]
RASGRF2 OT67DAGF Definitive Biomarker [565]
RCBTB1 OTAYELI8 Definitive Genetic Variation [570]
RNF213 OT4OVE9O Definitive Genetic Variation [575]
SORBS3 OTVEUODC Definitive Altered Expression [576]
------------------------------------------------------------------------------------
⏷ Show the Full List of 337 DOT(s)

References

1 Atorvastatin FDA Label
2 Fenofibrate FDA Label
3 ACR Appropriateness Criteria() Chronic Chest Pain-Noncardiac Etiology Unlikely-Low to Intermediate Probability of Coronary Artery Disease.J Am Coll Radiol. 2018 Nov;15(11S):S283-S290. doi: 10.1016/j.jacr.2018.09.021.
4 ADAM33 expression in atherosclerotic lesions and relationship of ADAM33 gene variation with atherosclerosis.Atherosclerosis. 2010 Jul;211(1):224-30. doi: 10.1016/j.atherosclerosis.2010.02.023. Epub 2010 Feb 24.
5 Association between ADAMTS1 matrix metalloproteinase gene variation, coronary heart disease, and benefit of statin therapy.Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):562-7. doi: 10.1161/ATVBAHA.107.156653. Epub 2008 Jan 3.
6 A novel association between TGFb1 and ADAMTS4 in coronary artery disease: A new potential mechanism in the progression of atherosclerosis and diabetes.Anatol J Cardiol. 2015 Oct;15(10):823-9. doi: 10.5152/akd.2014.5762. Epub 2014 Oct 31.
7 The transcriptome of human epicardial, mediastinal and subcutaneous adipose tissues in men with coronary artery disease.PLoS One. 2011;6(5):e19908. doi: 10.1371/journal.pone.0019908. Epub 2011 May 16.
8 A nonsynonymous variant I248L of the adenosine A3 receptor is associated with coronary heart disease in a Latvian population.DNA Cell Biol. 2011 Nov;30(11):907-11. doi: 10.1089/dna.2011.1230. Epub 2011 Jun 15.
9 2A-Adrenergic receptor polymorphism potentiates platelet reactivity in patients with stable coronary artery disease carrying the cytochrome P450 2C19*2 genetic variant.Arterioscler Thromb Vasc Biol. 2014 Jun;34(6):1314-9. doi: 10.1161/ATVBAHA.114.303275. Epub 2014 Apr 10.
10 Association of Improvement in Fractional Flow Reserve With Outcomes, Including Symptomatic Relief, After Percutaneous Coronary Intervention.JAMA Cardiol. 2019 Apr 1;4(4):370-374. doi: 10.1001/jamacardio.2019.0175.
11 Significant role of ADRB3 rs4994 towards the development of coronary artery disease.Coron Artery Dis. 2014 Jan;25(1):29-34. doi: 10.1097/MCA.0000000000000056.
12 Association of ALOX5AP haplotypes with susceptibility to coronary artery disease in a Chinese Han population.Eur J Intern Med. 2012 Jul;23(5):e119-23. doi: 10.1016/j.ejim.2012.02.010. Epub 2012 Mar 14.
13 Metabolomic Signature of Angiopoietin-Like Protein 3 Deficiency in Fasting and Postprandial State.Arterioscler Thromb Vasc Biol. 2019 Apr;39(4):665-674. doi: 10.1161/ATVBAHA.118.312021.
14 HDL subpopulations containing apoA-I without apoA-II (LpA-I) in patients with angiographically proven coronary artery disease.J Cardiol. 2017 Mar;69(3):523-528. doi: 10.1016/j.jjcc.2016.04.007. Epub 2016 May 8.
15 Association Between a CCL17 Genetic Variant and Risk of Coronary Artery Disease in a Chinese Han Population.Circ J. 2017 Dec 25;82(1):224-231. doi: 10.1253/circj.CJ-17-0190. Epub 2017 Aug 8.
16 Association of the CCR532 polymorphism and its ligand RANTES-403G/A polymorphism with coronary artery disease: a meta-analysis.Thromb Res. 2013 Mar;131(3):e77-84. doi: 10.1016/j.thromres.2012.07.024. Epub 2013 Jan 9.
17 Altered Expression of Complement Regulatory Proteins CD35, CD46, CD55, and CD59 on Leukocyte Subsets in Individuals Suffering From Coronary Artery Disease.Front Immunol. 2019 Aug 29;10:2072. doi: 10.3389/fimmu.2019.02072. eCollection 2019.
18 ACAT-1 gene polymorphism is associated with increased susceptibility to coronary artery disease in Chinese Han population: a case-control study.Oncotarget. 2017 Oct 6;8(51):89055-89063. doi: 10.18632/oncotarget.21649. eCollection 2017 Oct 24.
19 Genome-wide association study and targeted metabolomics identifies sex-specific association of CPS1 with coronary artery disease.Nat Commun. 2016 Jan 29;7:10558. doi: 10.1038/ncomms10558.
20 Relationship of Genetic Polymorphisms of Aldosterone Synthase Gene Cytochrome P450 11B2 and Mineralocorticoid Receptors with Coronary Artery Disease in Taiwan.Int J Med Sci. 2016 Feb 1;13(2):117-23. doi: 10.7150/ijms.13862. eCollection 2016.
21 Polymorphisms of CYP2C8, CYP2C9 and CYP2C19 and risk of coronary heart disease in Russian population.Gene. 2017 Sep 5;627:451-459. doi: 10.1016/j.gene.2017.07.004. Epub 2017 Jul 4.
22 Ophiopogonin D Reduces Myocardial Ischemia-Reperfusion Injury via Upregulating CYP2J3/EETs in Rats.Cell Physiol Biochem. 2018;49(4):1646-1658. doi: 10.1159/000493500. Epub 2018 Sep 18.
23 Impact of CYP3A5 polymorphism on platelet reactivity at percutaneous coronary intervention and after 9 months of aspirin and clopidogrel therapy in Japanese patients with coronary artery disease.Eur J Clin Pharmacol. 2014 Jun;70(6):667-73. doi: 10.1007/s00228-014-1672-3. Epub 2014 Apr 26.
24 C-338A polymorphism of the endothelin-converting enzyme (ECE-1) gene and the susceptibility to sporadic late-onset Alzheimer's disease and coronary artery disease.Dis Markers. 2008;24(3):175-9. doi: 10.1155/2008/578304.
25 ENPP1 K121Q (rs1044498C?A) genetic polymorphism confers a high risk of susceptibility to coronary heart disease: A PRISMA-compliant article.Medicine (Baltimore). 2018 Jul;97(27):e11236. doi: 10.1097/MD.0000000000011236.
26 Putting genome analysis to good use: lessons from C-reactive protein and cardiovascular disease.Cleve Clin J Med. 2012 Mar;79(3):182-91. doi: 10.3949/ccjm.79a.09169.
27 The tumour necrosis factor superfamily ligand APRIL (TNFSF13) is released upon platelet activation and expressed in atherosclerosis.Thromb Haemost. 2009 Oct;102(4):704-10. doi: 10.1160/TH08-10-0665.
28 C-reactive protein-derived peptide 201-206 inhibits neutrophil adhesion to endothelial cells and platelets through CD32.J Leukoc Biol. 2011 Dec;90(6):1167-75. doi: 10.1189/jlb.0111032. Epub 2011 Sep 20.
29 Fibroblast growth factor 21 in cardio-metabolic disorders: a systematic review and meta-analysis.Metabolism. 2018 Jun;83:11-17. doi: 10.1016/j.metabol.2018.01.017. Epub 2018 Feb 2.
30 Fibroblast growth factor receptor 4 polymorphisms and susceptibility to coronary artery disease.DNA Cell Biol. 2012 Jun;31(6):1064-9. doi: 10.1089/dna.2011.1552. Epub 2012 Feb 7.
31 Correlations of degree of coronary artery stenosis with blood lipid, CRP, Hcy, GGT, SCD36 and fibrinogen levels in elderly patients with coronary heart disease.Eur Rev Med Pharmacol Sci. 2019 Nov;23(21):9582-9589. doi: 10.26355/eurrev_201911_19453.
32 Human Epicardial Fat Expresses Glucagon-Like Peptide 1 and 2 Receptors Genes.Horm Metab Res. 2017 Aug;49(8):625-630. doi: 10.1055/s-0043-109563. Epub 2017 May 17.
33 Decreased levels of platelet-derived soluble glycoprotein VI detected prior to the first diagnosis of coronary artery disease in HIV-positive individuals.Platelets. 2017 May;28(3):301-304. doi: 10.1080/09537104.2016.1237627. Epub 2016 Nov 16.
34 Detecting local haplotype sharing and haplotype association.Genetics. 2014 Jul;197(3):823-38. doi: 10.1534/genetics.114.164814. Epub 2014 May 8.
35 Degradation of GRK2 and AKT is an early and detrimental event in myocardial ischemia/reperfusion.EBioMedicine. 2019 Oct;48:605-618. doi: 10.1016/j.ebiom.2019.09.019. Epub 2019 Oct 5.
36 The Atherosclerosis Risk Variant rs2107595 Mediates Allele-Specific Transcriptional Regulation of HDAC9 via E2F3 and Rb1.Stroke. 2019 Oct;50(10):2651-2660. doi: 10.1161/STROKEAHA.119.026112. Epub 2019 Sep 10.
37 Upregulation of microRNA-218 reduces cardiac microvascular endothelial cells injury induced by coronary artery disease through the inhibition of HMGB1.J Cell Physiol. 2020 Mar;235(3):3079-3095. doi: 10.1002/jcp.29214. Epub 2019 Sep 30.
38 Association of the HNF1A polymorphisms and serum lipid traits, the risk of coronary artery disease and ischemic stroke.J Gene Med. 2017 Jan;19(1-2):e2941. doi: 10.1002/jgm.2941.
39 Serum Heparanase Level Is Decreased in Stable Coronary Artery Disease.Med Princ Pract. 2019;28(6):573-580. doi: 10.1159/000503085. Epub 2019 Sep 4.
40 Genetic variations in HSPA8 gene associated with coronary heart disease risk in a Chinese population.PLoS One. 2010 Mar 16;5(3):e9684. doi: 10.1371/journal.pone.0009684.
41 T helper cellrelated cytokine gene polymorphisms and vitamin D pathway gene polymorphisms as predictors of survival probability in patients on renal replacement therapy.Pol Arch Med Wewn. 2015;125(7-8):511-20. doi: 10.20452/pamw.2957. Epub 2015 Jun 3.
42 Interleukin-15 and soluble interleukin-15 receptor in coronary artery disease patients: association with epicardial fat and indices of adipose tissue distribution.PLoS One. 2014 Mar 6;9(3):e90960. doi: 10.1371/journal.pone.0090960. eCollection 2014.
43 The association of interleukin-16 gene polymorphisms with susceptibility of coronary artery disease.Clin Biochem. 2013 Feb;46(3):241-4. doi: 10.1016/j.clinbiochem.2012.11.009. Epub 2012 Nov 27.
44 The IL-33-ST2L pathway is associated with coronary artery disease in a Chinese Han population.Am J Hum Genet. 2013 Oct 3;93(4):652-60. doi: 10.1016/j.ajhg.2013.08.009. Epub 2013 Sep 26.
45 The association between IL-17A and IL-23R polymorphisms and coronary artery disease risk in a Middle Eastern Chinese population.J Clin Lab Anal. 2019 Jul;33(6):e22893. doi: 10.1002/jcla.22893. Epub 2019 May 10.
46 Circulating Levels of LAMP2 in Coronary Artery Disease: Association with Serum Lipid Profile.Horm Metab Res. 2017 Feb;49(2):109-114. doi: 10.1055/s-0042-119649. Epub 2016 Dec 6.
47 Is Chronic Low Back Pain Associated with the Prevalence of Coronary Heart Disease when Genetic Susceptibility Is Considered? A Co-Twin Control Study of Spanish Twins.PLoS One. 2016 May 12;11(5):e0155194. doi: 10.1371/journal.pone.0155194. eCollection 2016.
48 Lysosomal Acid Lipase in Lipid Metabolism and Beyond.Arterioscler Thromb Vasc Biol. 2019 May;39(5):850-856. doi: 10.1161/ATVBAHA.119.312136.
49 Association of 584C/T polymorphism in endothelial lipase gene with risk of coronary artery disease.J Cell Biochem. 2019 Sep;120(9):14414-14420. doi: 10.1002/jcb.28697. Epub 2019 Apr 24.
50 TCF7L2 (Transcription Factor 7-Like 2) Regulation of GATA6 (GATA-Binding Protein 6)-Dependent and -Independent Vascular Smooth Muscle Cell Plasticity and Intimal Hyperplasia.Arterioscler Thromb Vasc Biol. 2019 Feb;39(2):250-262. doi: 10.1161/ATVBAHA.118.311830.
51 Extended evidence for association between the melanoma inhibitory activity 3 gene and myocardial infarction.Thromb Haemost. 2011 Apr;105(4):670-5. doi: 10.1160/TH10-10-0641. Epub 2011 Jan 25.
52 The effect of MVK-MMAB variants, their haplotypes and GE interactions on serum lipid levels and the risk of coronary heart disease and ischemic stroke.Oncotarget. 2017 Aug 18;8(42):72801-72817. doi: 10.18632/oncotarget.20349. eCollection 2017 Sep 22.
53 Association of 25 bp deletion in MYBPC3 gene with left ventricle dysfunction in coronary artery disease patients.PLoS One. 2011;6(9):e24123. doi: 10.1371/journal.pone.0024123. Epub 2011 Sep 7.
54 Mutant DD genotype of NFKB1 gene is associated with the susceptibility and severity of coronary artery disease.J Mol Cell Cardiol. 2017 Feb;103:56-64. doi: 10.1016/j.yjmcc.2017.01.005. Epub 2017 Jan 12.
55 Genetics of adipose tissue biology.Prog Mol Biol Transl Sci. 2010;94:39-74. doi: 10.1016/B978-0-12-375003-7.00003-0.
56 High doses of ANP and BNP exacerbate lipolysis in humans and the lipolytic effect of BNP is associated with cardiac triglyceride content in pigs.Peptides. 2019 Feb;112:43-47. doi: 10.1016/j.peptides.2018.11.003. Epub 2018 Nov 30.
57 Medications that reduce emergency hospital admissions: an overview of systematic reviews and prioritisation of treatments.BMC Med. 2018 Jul 26;16(1):115. doi: 10.1186/s12916-018-1104-9.
58 Successful intravenous thrombolysis for ischemic stroke as a complication of coronary intervention in patients with ticagrelor pretreatment.J Clin Neurosci. 2020 Jan;71:283-286. doi: 10.1016/j.jocn.2019.10.007. Epub 2019 Oct 26.
59 Genetic variants in PCSK1 gene are associated with the risk of coronary artery disease in type 2 diabetes in a Chinese Han population: a case control study.PLoS One. 2014 Jan 28;9(1):e87168. doi: 10.1371/journal.pone.0087168. eCollection 2014.
60 PDE4D gene polymorphisms and coronary heart disease: a case-control study in a north Indian population.J Clin Lab Anal. 2013 Jul;27(4):297-300. doi: 10.1002/jcla.21601.
61 Associations between the CDKN2A/B, ADTRP and PDGFD polymorphisms and the development of coronary atherosclerosis in Japanese patients.J Atheroscler Thromb. 2014;21(7):680-90. doi: 10.5551/jat.22640. Epub 2014 Mar 26.
62 Decoy receptor-3 regulates inflammation and apoptosis via PI3K/AKT signaling pathway in coronary heart disease.Exp Ther Med. 2019 Apr;17(4):2614-2622. doi: 10.3892/etm.2019.7222. Epub 2019 Jan 30.
63 Platelet surface expression of cyclophilin A is associated with increased mortality in patients with symptomatic coronary artery disease.J Thromb Haemost. 2020 Jan;18(1):234-242. doi: 10.1111/jth.14635. Epub 2019 Oct 20.
64 The role of PRKCH gene variants in coronary artery disease in a Chinese population.Mol Biol Rep. 2012 Feb;39(2):1777-82. doi: 10.1007/s11033-011-0918-8. Epub 2011 May 29.
65 Serum retinol-binding protein 4 is associated with the presence and severity of coronary artery disease in patients with subclinical hypothyroidism.Aging (Albany NY). 2019 Jul 6;11(13):4510-4520. doi: 10.18632/aging.102065.
66 SENP1 protects against myocardial ischaemia/reperfusion injury via a HIF1-dependent pathway.Cardiovasc Res. 2014 Oct 1;104(1):83-92. doi: 10.1093/cvr/cvu177. Epub 2014 Jul 31.
67 PHACTR1 and SLC22A3 gene polymorphisms are associated with reduced coronary artery disease risk in the male Chinese Han population.Oncotarget. 2017 Jan 3;8(1):658-663. doi: 10.18632/oncotarget.13506.
68 Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk.PLoS Genet. 2018 Oct 11;14(10):e1007681. doi: 10.1371/journal.pgen.1007681. eCollection 2018 Oct.
69 Association between a thyroid hormone receptor- gene polymorphism and blood pressure but not with coronary heart disease risk.Am J Hypertens. 2011 Sep;24(9):1027-34. doi: 10.1038/ajh.2011.94. Epub 2011 Jun 9.
70 Toll-like receptor 8 polymorphism and coronary artery disease.Mol Biol Rep. 2009 Sep;36(7):1897-901. doi: 10.1007/s11033-008-9396-z. Epub 2008 Nov 5.
71 T4 Increases Neovascularization and Cardiac Function in Chronic Myocardial Ischemia of Normo- and Hypercholesterolemic Pigs.Mol Ther. 2018 Jul 5;26(7):1706-1714. doi: 10.1016/j.ymthe.2018.06.004. Epub 2018 Jun 19.
72 Predictive Value of Osteoprotegerin for Detecting Coronary Artery Calcification in Type 2 Diabetes Mellitus Patients in Correlation with Extent of Calcification Detected by Multidetector Computed Tomography.Endocr Metab Immune Disord Drug Targets. 2019;19(6):845-851. doi: 10.2174/1871530319666190211122858.
73 Clinical significance of costimulatory molecules CD40/CD40L and CD134/CD134L in coronary heart disease: A case-control study.Medicine (Baltimore). 2017 Aug;96(32):e7634. doi: 10.1097/MD.0000000000007634.
74 The role of OX40L and ICAM-1 in the stability of coronary atherosclerotic plaques and their relationship with sudden coronary death.BMC Cardiovasc Disord. 2019 Nov 29;19(1):272. doi: 10.1186/s12872-019-1251-8.
75 VKORC1 rs2359612C allele is associated with increased risk of coronary artery disease in the presence of coronary calcification.Hum Genet. 2013 Jan;132(1):29-37. doi: 10.1007/s00439-012-1222-y. Epub 2012 Aug 23.
76 Effect of ZNF217 gene polymorphisms on colorectal cancer development in a Mexican population.Genet Mol Res. 2015 Jan 23;14(1):362-7. doi: 10.4238/2015.January.23.9.
77 Genomic structural variations for cardiovascular and metabolic comorbidity.Sci Rep. 2017 Jan 25;7:41268. doi: 10.1038/srep41268.
78 Epigenetics-by-Sex Interaction for Coronary Artery Disease Risk Conferred by the Cystathionine -Lyase Gene Promoter Methylation.OMICS. 2017 Dec;21(12):741-748. doi: 10.1089/omi.2017.0149. Epub 2017 Nov 27.
79 Relation of coagulation factor XI with incident coronary heart disease and stroke: the Cardiovascular Health Study.Blood Coagul Fibrinolysis. 2017 Jul;28(5):389-392. doi: 10.1097/MBC.0000000000000616.
80 International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries.Am Heart J. 2017 Dec;194:132-140. doi: 10.1016/j.ahj.2017.08.011. Epub 2017 Aug 24.
81 Attenuating myocardial ischemia by targeting A2B adenosine receptors.Trends Mol Med. 2013 Jun;19(6):345-54. doi: 10.1016/j.molmed.2013.02.005. Epub 2013 Mar 26.
82 Relationship between circulating levels of angiotensin-converting enzyme 2-angiotensin-(1-7)-MAS axis and coronary heart disease.Heart Vessels. 2020 Feb;35(2):153-161. doi: 10.1007/s00380-019-01478-y. Epub 2019 Jul 29.
83 Arginase-2 protects myocardial ischemia-reperfusion injury via NF-B/TNF- pathway.Eur Rev Med Pharmacol Sci. 2018 Oct;22(19):6529-6537. doi: 10.26355/eurrev_201810_16067.
84 -arrestin2 Affects Cardiac Progenitor Cell Survival through Cell Mobility and Tube Formation in Severe Hypoxia.Korean Circ J. 2018 Apr;48(4):296-309. doi: 10.4070/kcj.2017.0119.
85 Sequence and time course of depletion of cardiac cellular proteins and accumulation of plasma proteins in rat early ischemic myocardium.Leg Med (Tokyo). 2019 May;38:36-44. doi: 10.1016/j.legalmed.2019.04.001. Epub 2019 Apr 2.
86 Comparison of Framingham risk score and chest-CT identified coronary artery calcification in breast cancer patients to predict cardiovascular events.Int J Cardiol. 2019 Aug 15;289:138-143. doi: 10.1016/j.ijcard.2019.01.056. Epub 2019 Jan 23.
87 Common and Rare Genetic Variation in CCR2, CCR5, or CX3CR1 and Risk of Atherosclerotic Coronary Heart Disease and Glucometabolic Traits.Circ Cardiovasc Genet. 2016 Jun;9(3):250-8. doi: 10.1161/CIRCGENETICS.115.001374. Epub 2016 Mar 24.
88 TXNIP/Redd1 signalling and excessive autophagy: a novel mechanism of myocardial ischaemia/reperfusion injury in mice.Cardiovasc Res. 2020 Mar 1;116(3):645-657. doi: 10.1093/cvr/cvz152.
89 Secreted tyrosine sulfated-eIF5A mediates oxidative stress-induced apoptosis.Sci Rep. 2015 Sep 8;5:13737. doi: 10.1038/srep13737.
90 Modulation of gene expression by Polyalthia longifolia in postmenopausal women with coronary artery disease: an in vitro study. J Cardiovasc Transl Res. 2010 Oct;3(5):570-9.
91 Activation of cardiac AMPK-FGF21 feed-forward loop in acute myocardial infarction: Role of adrenergic overdrive and lipolysis byproducts.Sci Rep. 2019 Aug 14;9(1):11841. doi: 10.1038/s41598-019-48356-1.
92 Fucosyltransferase 3 polymorphism and atherothrombotic disease in the Framingham Offspring Study.Am Heart J. 2007 Apr;153(4):636-9. doi: 10.1016/j.ahj.2006.12.015.
93 GCH1 haplotype determines vascular and plasma biopterin availability in coronary artery disease effects on vascular superoxide production and endothelial function.J Am Coll Cardiol. 2008 Jul 8;52(2):158-65. doi: 10.1016/j.jacc.2007.12.062.
94 Differential indication for SGLT-2 inhibitors versus GLP-1 receptor agonists in patients with established atherosclerotic heart disease or at risk for congestive heart failure.Metabolism. 2020 Mar;104:154045. doi: 10.1016/j.metabol.2019.154045. Epub 2019 Dec 7.
95 Pharmacological effects of lipid-lowering drugs recapitulate with a larger amplitude the phenotypic effects of common variants within their target genes.Pharmacogenet Genomics. 2008 Dec;18(12):1051-7. doi: 10.1097/FPC.0b013e32831270eb.
96 Prognostic impact of Interleukin-1 receptor antagonist in patients with documented coronary artery disease.Int J Cardiol. 2018 Apr 15;257:24-29. doi: 10.1016/j.ijcard.2018.01.055. Epub 2018 Feb 1.
97 Expression of miR-146a/b is associated with the Toll-like receptor 4 signal in coronary artery disease: effect of renin-angiotensin system blockade and statins on miRNA-146a/b and Toll-like receptor 4 levels.Clin Sci (Lond). 2010 Jul 23;119(9):395-405. doi: 10.1042/CS20100003.
98 Modulation of Ion Channels in the Superior Cervical Ganglion Neurons by Myocardial Ischemia and Fluvastatin Treatment.Front Physiol. 2018 Sep 10;9:1157. doi: 10.3389/fphys.2018.01157. eCollection 2018.
99 Kallikrein gene delivery attenuates myocardial infarction and apoptosis after myocardial ischemia and reperfusion.Hypertension. 2000 Jan;35(1 Pt 1):25-31. doi: 10.1161/01.hyp.35.1.25.
100 Associations of leptin and leptin receptor genetic variants with coronary artery disease: a meta-analysis.Biosci Rep. 2019 Jun 10;39(6):BSR20190466. doi: 10.1042/BSR20190466. Print 2019 Jun 28.
101 Lysyl oxidase G473A polymorphism is associated with increased risk of coronary artery diseases.DNA Cell Biol. 2011 Dec;30(12):1033-7. doi: 10.1089/dna.2011.1261. Epub 2011 May 25.
102 A functional variant in the CARD4 gene and risk of premature coronary heart disease.Int J Immunogenet. 2006 Aug;33(4):307-11. doi: 10.1111/j.1744-313X.2006.00618.x.
103 Knockdown the P2X3 receptor in the stellate ganglia of rats relieved the diabetic cardiac autonomic neuropathy.Neurochem Int. 2018 Nov;120:206-212. doi: 10.1016/j.neuint.2018.09.002. Epub 2018 Sep 6.
104 Abnormal sympathetic activity after myocardial ischemia involving P2X4 in dorsal root ganglia.Brain Res Bull. 2019 Jul;149:216-221. doi: 10.1016/j.brainresbull.2019.04.024. Epub 2019 Apr 30.
105 Stimulation of murine P2Y11-like purinoreceptor protects against hypoxia/reoxygenation injury and decreases heart graft rejection lesions.J Thorac Cardiovasc Surg. 2019 Sep;158(3):780-790.e1. doi: 10.1016/j.jtcvs.2018.12.014. Epub 2018 Dec 21.
106 Protective effects of circulating microvesicles derived from myocardial ischemic rats on apoptosis of cardiomyocytes in myocardial ischemia/reperfusion injury.Oncotarget. 2017 Apr 26;8(33):54572-54582. doi: 10.18632/oncotarget.17424. eCollection 2017 Aug 15.
107 Targeting PPAR for the Treatment and Understanding of Cardiovascular Diseases.Cell Physiol Biochem. 2018;51(6):2760-2775. doi: 10.1159/000495969. Epub 2018 Dec 12.
108 Association of the R485K polymorphism of the factor V gene with poor response to activated protein C and increased risk of coronary artery disease in the Chinese population.Clin Genet. 2000 Apr;57(4):296-303. doi: 10.1034/j.1399-0004.2000.570409.x.
109 An alternative mitophagy pathway mediated by Rab9 protects the heart against ischemia.J Clin Invest. 2019 Feb 1;129(2):802-819. doi: 10.1172/JCI122035. Epub 2019 Jan 22.
110 Cardioprotective effects of a Fructus Aurantii polysaccharide in isoproterenol-induced myocardial ischemic rats.Int J Biol Macromol. 2020 Jul 15;155:995-1002. doi: 10.1016/j.ijbiomac.2019.11.063. Epub 2019 Nov 8.
111 Differential association of common carotid intima-media thickness and carotid atherosclerotic plaques with parental history of premature death from coronary heart disease : the EVA study.Arterioscler Thromb Vasc Biol. 1999 Feb;19(2):366-71. doi: 10.1161/01.atv.19.2.366.
112 Sodium-Hydrogen Exchanger Isoform-1 Inhibition: A Promising Pharmacological Intervention for Resuscitation from Cardiac Arrest.Molecules. 2019 May 7;24(9):1765. doi: 10.3390/molecules24091765.
113 Hypoalphalipoproteinaemia and polymorphisms associated with reduced expression of the apolipoprotein A-I gene and resolution of disputed paternity in a large English family.Clin Genet. 1993 Jan;43(1):39-43. doi: 10.1111/j.1399-0004.1993.tb04424.x.
114 Salvianolic acid A targeting the transgelin-actin complex to enhance vasoconstriction.EBioMedicine. 2018 Nov;37:246-258. doi: 10.1016/j.ebiom.2018.10.041. Epub 2018 Oct 23.
115 Involvement of native TRPC3 proteins in ATP-dependent expression of VCAM-1 and monocyte adherence in coronary artery endothelial cells.Arterioscler Thromb Vasc Biol. 2008 Nov;28(11):2049-55. doi: 10.1161/ATVBAHA.108.175356. Epub 2008 Sep 11.
116 Regulation of VDAC1 contributes to the cardioprotective effects of penehyclidine hydrochloride during myocardial ischemia/reperfusion.Exp Cell Res. 2018 Jun 15;367(2):257-263. doi: 10.1016/j.yexcr.2018.04.004. Epub 2018 Apr 6.
117 Diminished 25-OH vitamin D(3) levels and vitamin D receptor variants are associated with susceptibility to type 2 diabetes with coronary artery diseases.J Clin Lab Anal. 2020 Apr;34(4):e23137. doi: 10.1002/jcla.23137. Epub 2019 Dec 3.
118 Episodic coronary artery vasospasm and hypertension develop in the absence of Sur2 K(ATP) channels.J Clin Invest. 2002 Jul;110(2):203-8. doi: 10.1172/JCI15672.
119 A polymorphism in the ABCG1 promoter is functionally associated with coronary artery disease in a Chinese Han population.Atherosclerosis. 2011 Dec;219(2):648-54. doi: 10.1016/j.atherosclerosis.2011.05.043. Epub 2011 Jun 17.
120 ABCG5/8 variants are associated with susceptibility to coronary heart disease.Mol Med Rep. 2014 Jun;9(6):2512-20. doi: 10.3892/mmr.2014.2098. Epub 2014 Apr 1.
121 Serum adenosine deaminase activity and coronary artery disease: a retrospective case-control study based on 9929 participants.Ther Adv Chronic Dis. 2019 Dec 6;10:2040622319891539. doi: 10.1177/2040622319891539. eCollection 2019.
122 ADAM8 and its single nucleotide polymorphism 2662 T/G are associated with advanced atherosclerosis and fatal myocardial infarction: Tampere vascular study.Ann Med. 2009;41(7):497-507. doi: 10.1080/07853890903025945.
123 The role of ADAMTS13 testing in the diagnosis and management of thrombotic microangiopathies and thrombosis.Blood. 2018 Aug 30;132(9):903-910. doi: 10.1182/blood-2018-02-791533. Epub 2018 Jul 13.
124 Does alpha-1-proteinase inhibitor play a protective role in coronary atherosclerosis?.Med Sci Monit. 2001 Jul-Aug;7(4):701-11.
125 High Resting Heart Rate and High BMI Predicted Severe Coronary Atherosclerosis Burden in Patients With Stable Angina Pectoris by SYNTAX Score.Angiology. 2018 May;69(5):380-386. doi: 10.1177/0003319717715579. Epub 2017 Jun 21.
126 Lower Plasma Fetuin-A Levels Are Associated With a Higher Mortality Risk in Patients With Coronary Artery Disease.Arterioscler Thromb Vasc Biol. 2017 Nov;37(11):2213-2219. doi: 10.1161/ATVBAHA.117.309700. Epub 2017 Sep 14.
127 Aldose reductase modulates acute activation of mesenchymal markers via the -catenin pathway during cardiac ischemia-reperfusion.PLoS One. 2017 Nov 30;12(11):e0188981. doi: 10.1371/journal.pone.0188981. eCollection 2017.
128 Interaction between ALOX15 polymorphisms and coronary artery disease in North Indian population.Clin Exp Hypertens. 2018;40(4):398-405. doi: 10.1080/10641963.2017.1384485. Epub 2017 Oct 25.
129 Discovery and Early Clinical Development of an Inhibitor of 5-Lipoxygenase Activating Protein (AZD5718) for Treatment of Coronary Artery Disease.J Med Chem. 2019 May 9;62(9):4312-4324. doi: 10.1021/acs.jmedchem.8b02004. Epub 2019 Mar 26.
130 Homoarginine Supplementation Prevents Left Ventricular Dilatation and Preserves Systolic Function in a Model of Coronary Artery Disease.J Am Heart Assoc. 2019 Jul 16;8(14):e012486. doi: 10.1161/JAHA.119.012486. Epub 2019 Jul 15.
131 Prognostic value of angiopoietin-2 for patients with coronary heart disease after elective PCI.Medicine (Baltimore). 2019 Feb;98(5):e14216. doi: 10.1097/MD.0000000000014216.
132 New insights into angiopoietin-like proteins in lipid metabolism and cardiovascular disease risk.Curr Opin Lipidol. 2019 Jun;30(3):205-211. doi: 10.1097/MOL.0000000000000600.
133 Elevated C-reactive protein levels are associated with endothelial dysfunction in chronic cocaine users. Int J Cardiol. 2003 Apr;88(2-3):191-8. doi: 10.1016/s0167-5273(02)00394-7.
134 Effects of iloprost and sildenafil treatment on elabela, apelin-13, nitric oxide, and total antioxidant and total oxidant status in experimental enzyme-positive acute coronary syndrome in rats.Biotech Histochem. 2020 Feb;95(2):145-151. doi: 10.1080/10520295.2019.1653497. Epub 2019 Aug 20.
135 Effects of Polymorphisms in APOA4-APOA5-ZNF259-BUD13 Gene Cluster on Plasma Levels of Triglycerides and Risk of Coronary Heart Disease in a Chinese Han Population.PLoS One. 2015 Sep 23;10(9):e0138652. doi: 10.1371/journal.pone.0138652. eCollection 2015.
136 Relationship of lipoprotein-associated apolipoprotein C-III with lipid variables and coronary artery disease risk: The EPIC-Norfolk prospective population study.J Clin Lipidol. 2018 Nov-Dec;12(6):1493-1501.e11. doi: 10.1016/j.jacl.2018.08.010. Epub 2018 Aug 29.
137 Differences in total blood loss and transfusion rate between different indications for shoulder arthroplasty.Int Orthop. 2019 Mar;43(3):653-658. doi: 10.1007/s00264-018-4047-z. Epub 2018 Aug 3.
138 New insights into the role of glycosylation in lipoprotein metabolism.Curr Opin Lipidol. 2017 Dec;28(6):502-506. doi: 10.1097/MOL.0000000000000461.
139 Abnormal cardiac autonomic regulation in mice lacking ASIC3.Biomed Res Int. 2014;2014:709159. doi: 10.1155/2014/709159. Epub 2014 Apr 3.
140 Effect of intensive lipid-lowering therapies on cholinesterase activity in patients with coronary artery disease.Pharmacol Rep. 2017 Feb;69(1):150-155. doi: 10.1016/j.pharep.2016.09.016. Epub 2016 Sep 21.
141 CACNA1C gene polymorphisms, cardiovascular disease outcomes, and treatment response. Circ Cardiovasc Genet. 2009 Aug;2(4):362-70. doi: 10.1161/CIRCGENETICS.109.857839. Epub 2009 Jun 3.
142 DASH diet decreases CXCL4 plasma concentration in patients diagnosed with coronary atherosclerotic lesions.Nutr Metab Cardiovasc Dis. 2020 Jan 3;30(1):56-59. doi: 10.1016/j.numecd.2019.07.013. Epub 2019 Jul 24.
143 Genetic variation of the methylenetetrahydrofolate reductase and cystathionine beta-synthase genes in Korean patients with coronary artery disease and a new polymorphism in intron 7.Mol Cell Probes. 2001 Apr;15(2):119-23. doi: 10.1006/mcpr.2001.0351.
144 Association of Cyr61-cysteine-rich protein 61 and short-term mortality in patients with acute heart failure and coronary heart disease.Biomark Med. 2019 Dec;13(18):1589-1597. doi: 10.2217/bmm-2019-0111. Epub 2019 Oct 29.
145 Angiotensin-converting enzyme inhibition down-regulates the pro-atherogenic chemokine receptor 9 (CCR9)-chemokine ligand 25 (CCL25) axis.J Biol Chem. 2010 Jul 23;285(30):23496-505. doi: 10.1074/jbc.M110.117481. Epub 2010 May 26.
146 [Effects of electroacupuncture intervention on blood lipid levels and expression of CD 40 L and MMP-9 in the coronary artery tissue in coronary heart disease rats].Zhen Ci Yan Jiu. 2013 Apr;38(2):123-8.
147 Novel risk genes identified in a genome-wide association study for coronary artery disease in patients with type 1 diabetes.Cardiovasc Diabetol. 2018 Apr 25;17(1):61. doi: 10.1186/s12933-018-0705-0.
148 Association of TAFI gene polymorphisms with severity of coronary stenosis in stable coronary artery disease.Thromb Res. 2018 Nov;171:171-176. doi: 10.1016/j.thromres.2018.10.001. Epub 2018 Oct 3.
149 Association of the mutation for the human carboxypeptidase E gene exon 4 with the severity of coronary artery atherosclerosis.Mol Biol Rep. 2009 Feb;36(2):245-54. doi: 10.1007/s11033-007-9173-4. Epub 2007 Dec 16.
150 Complement receptor 1 gene polymorphisms are associated with cardiovascular risk.Atherosclerosis. 2017 Feb;257:16-21. doi: 10.1016/j.atherosclerosis.2016.12.017. Epub 2016 Dec 20.
151 Cysteine Protease Cathepsins in Atherosclerotic Cardiovascular Diseases.J Atheroscler Thromb. 2018 Feb 1;25(2):111-123. doi: 10.5551/jat.RV17016. Epub 2017 Oct 5.
152 Associations between polymorphisms of the CXCL12 and CNNM2 gene and hypertension risk: A case-control study.Gene. 2018 Oct 30;675:185-190. doi: 10.1016/j.gene.2018.06.107. Epub 2018 Jul 2.
153 CYP17A1 Polymorphisms Are Linked to the Risk of Coronary Heart Disease in a Case-Control Study.J Cardiovasc Pharmacol. 2019 Aug;74(2):98-104. doi: 10.1097/FJC.0000000000000687.
154 CYP2D6 (C2850T, G1846A, C100T) polymorphisms, haplotypes and MDR analysis in predicting coronary artery disease risk in north-west Indian population: A case-control study.Gene. 2018 Jul 15;663:17-24. doi: 10.1016/j.gene.2018.04.008. Epub 2018 Apr 13.
155 Plasma miR-142 accounting for the missing heritability of CYP3A4/5 functionality is associated with pharmacokinetics of clopidogrel.Pharmacogenomics. 2016 Sep;17(14):1503-17. doi: 10.2217/pgs-2016-0027. Epub 2016 Aug 24.
156 Cysteinyl leukotriene signaling aggravates myocardial hypoxia in experimental atherosclerotic heart disease.PLoS One. 2012;7(7):e41786. doi: 10.1371/journal.pone.0041786. Epub 2012 Jul 25.
157 Preliminary evaluation of 18FAlFNOTAMALCys40Exendin? in rodent heart after myocardial ischemia and reperfusion.Mol Med Rep. 2019 Sep;20(3):2276-2284. doi: 10.3892/mmr.2019.10432. Epub 2019 Jun 27.
158 Effects of GCN2/eIF2 on myocardial ischemia/hypoxia reperfusion and myocardial cells injury.Am J Transl Res. 2019 Sep 15;11(9):5586-5598. eCollection 2019.
159 Association between polymorphisms of CYP2J2 and EPHX2 genes and risk of coronary artery disease.Pharmacogenet Genomics. 2011 Aug;21(8):489-94. doi: 10.1097/FPC.0b013e3283485eb2.
160 Effect of Empagliflozin on Erythropoietin Levels, Iron Stores, and Red Blood Cell Morphology in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease.Circulation. 2020 Feb 25;141(8):704-707. doi: 10.1161/CIRCULATIONAHA.119.044235. Epub 2019 Nov 11.
161 Protease-Activated Receptor-2 Plays a Critical Role in Vascular Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice.Circulation. 2018 Oct 16;138(16):1706-1719. doi: 10.1161/CIRCULATIONAHA.118.033544.
162 Homozygosity of the T allele of the 46 C-->T polymorphism in the F12 gene is a risk factor for acute coronary artery disease in the Spanish population.Haematologica. 2004 Jul;89(7):878-9.
163 Correlation of hypertension and F2RL3 gene methylation with Prognosis of coronary heart disease.J Biol Regul Homeost Agents. 2018 Nov-Dec;32(6):1539-1544.
164 Identification of a new adtrp1-tfpi regulatory axis for the specification of primitive myelopoiesis and definitive hematopoiesis.FASEB J. 2018 Jan;32(1):183-194. doi: 10.1096/fj.201700166RR. Epub 2017 Sep 6.
165 The association between Factor V Leiden with the presence and severity of coronary artery disease.Clin Biochem. 2014 Apr;47(6):356-60. doi: 10.1016/j.clinbiochem.2013.12.006. Epub 2013 Dec 17.
166 Contribution of coagulation factor VII R353Q, -323P0/10 and HVR4 polymorphisms to coronary artery disease in Tunisians.J Thromb Thrombolysis. 2013 Feb;35(2):243-9. doi: 10.1007/s11239-012-0800-0.
167 Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile.Blood. 2010 Dec 16;116(25):5688-97. doi: 10.1182/blood-2010-03-277079. Epub 2010 Sep 1.
168 Author Correction: The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease.Sci Rep. 2019 Mar 13;9(1):4838. doi: 10.1038/s41598-018-36737-x.
169 Association of Nonalcoholic Fatty Liver Disease and Coronary Artery Disease with FADS2 rs3834458 Gene Polymorphism in the Chinese Han Population.Gastroenterol Res Pract. 2019 Nov 3;2019:6069870. doi: 10.1155/2019/6069870. eCollection 2019.
170 Role of activating FcR gene polymorphisms in Kawasaki disease susceptibility and intravenous immunoglobulin response.Circ Cardiovasc Genet. 2012 Jun;5(3):309-16. doi: 10.1161/CIRCGENETICS.111.962464. Epub 2012 May 7.
171 Reduction in CD16/CD56 and CD16/CD3/CD56 Natural Killer Cells in Coronary Artery Disease.Immunol Invest. 2017 Jul;46(5):526-535. doi: 10.1080/08820139.2017.1306866. Epub 2017 Apr 17.
172 Overexpression of farnesyl pyrophosphate synthase increases myocardial ischemia/reperfusion injury in mice.Gene. 2018 Sep 25;672:72-78. doi: 10.1016/j.gene.2018.05.116. Epub 2018 Jun 1.
173 Intracoronary delivery of an adenovirus encoding fibroblast growth factor-4 in myocardial ischemia: effect of serum antibodies and previous exposure to adenovirus.Hum Gene Ther. 2006 Feb;17(2):230-8. doi: 10.1089/hum.2006.17.230.
174 Role of a common variant of Fat Mass and Obesity associated (FTO) gene in obesity and coronary artery disease in subjects from Punjab, Pakistan: a case control study.Lipids Health Dis. 2016 Feb 16;15:29. doi: 10.1186/s12944-016-0200-0.
175 GCK gene-body hypomethylation is associated with the risk of coronary heart disease.Biomed Res Int. 2014;2014:151723. doi: 10.1155/2014/151723. Epub 2014 Feb 17.
176 Potential relation between soluble growth differentiation factor-15 and testosterone deficiency in male patients with coronary artery disease.Cardiovasc Diabetol. 2019 Feb 28;18(1):21. doi: 10.1186/s12933-019-0823-3.
177 Improving myocardial fractional flow reserve in coronary atherosclerosis via CX37 gene silence: a preclinical validation study in pigs.Interact Cardiovasc Thorac Surg. 2018 Jan 1;26(1):139-145. doi: 10.1093/icvts/ivx218.
178 Glyoxalase 1 Prevents Chronic Hyperglycemia Induced Heart-Explant Derived Cell Dysfunction.Theranostics. 2019 Aug 9;9(19):5720-5730. doi: 10.7150/thno.36639. eCollection 2019.
179 Association between polymorphisms of platelet membrane glycoprotein Ib and risk of coronary heart disease in Han Chinese, Henan, China.Int J Clin Exp Pathol. 2015 May 1;8(5):6005-11. eCollection 2015.
180 Association between Polymorphisms of Antioxidant Gene (MnSOD, CAT, and GPx1) and Risk of Coronary Artery Disease.Biomed Res Int. 2018 Aug 26;2018:5086869. doi: 10.1155/2018/5086869. eCollection 2018.
181 Hemoglobins emerging roles in mental disorders. Metabolical, genetical and immunological aspects.Int J Dev Neurosci. 2017 Oct;61:73-85. doi: 10.1016/j.ijdevneu.2017.06.007. Epub 2017 Jul 8.
182 Pleiotropic effects of statins on acute kidney injury: involvement of Krppel-like factor 4.Clin Exp Nephrol. 2017 Apr;21(2):175-181. doi: 10.1007/s10157-016-1286-4. Epub 2016 Jun 13.
183 Protective effect of HSP27 in atherosclerosis and coronary heart disease by inhibiting reactive oxygen species.J Cell Biochem. 2019 Mar;120(3):2859-2868. doi: 10.1002/jcb.26575. Epub 2018 Dec 3.
184 Vitamin D supplementation and serum heat shock protein 60 levels in patients with coronary heart disease: a randomized clinical trial.Nutr Metab (Lond). 2018 Aug 6;15:56. doi: 10.1186/s12986-018-0292-9. eCollection 2018.
185 Transgenic Overexpression of IL-37 Protects Against Atherosclerosis and Strengthens Plaque Stability.Cell Physiol Biochem. 2018;45(3):1034-1050. doi: 10.1159/000487344. Epub 2018 Feb 7.
186 MicroRNA-128 confers protection against cardiac microvascular endothelial cell injury in coronary heart disease via negative regulation of IRS1.J Cell Physiol. 2019 Aug;234(8):13452-13463. doi: 10.1002/jcp.28025. Epub 2019 Jan 30.
187 Genetic risk score (GRS) constructed from polymorphisms in the PON1, IL-6, ITGB3, and ALDH2 genes is associated with the risk of coronary artery disease in Pakistani subjects.Lipids Health Dis. 2018 Sep 27;17(1):224. doi: 10.1186/s12944-018-0874-6.
188 Histone demethylase KDM3a, a novel regulator of vascular smooth muscle cells, controls vascular neointimal hyperplasia in diabetic rats.Atherosclerosis. 2017 Feb;257:152-163. doi: 10.1016/j.atherosclerosis.2016.12.007. Epub 2016 Dec 9.
189 Pathophysiology of genetic deficiency in tissue kallikrein activity in mouse and man.Thromb Haemost. 2013 Sep;110(3):476-83. doi: 10.1160/TH12-12-0937. Epub 2013 Apr 4.
190 Prospective study of plasma high molecular weight kininogen and prekallikrein and incidence of coronary heart disease, ischemic stroke and heart failure.Thromb Res. 2019 Oct;182:89-94. doi: 10.1016/j.thromres.2019.08.009. Epub 2019 Aug 22.
191 Increased risk of coronary artery disease in Caucasians with extremely low HDL cholesterol due to mutations in ABCA1, APOA1, and LCAT.Biochim Biophys Acta. 2012 Mar;1821(3):416-24. doi: 10.1016/j.bbalip.2011.08.006. Epub 2011 Aug 19.
192 Association Between Plasma Neutrophil Gelatinase-Associated Lipocalin and Cardiac Disease Hospitalizations and Deaths in Older Women.J Am Heart Assoc. 2019 Jan 8;8(1):e011028. doi: 10.1161/JAHA.118.011028.
193 Human Gain-of-Function MC4R Variants Show Signaling Bias and Protect against Obesity.Cell. 2019 Apr 18;177(3):597-607.e9. doi: 10.1016/j.cell.2019.03.044.
194 Regulation of MFGE8 by the intergenic coronary artery disease locus on 15q26.1.Atherosclerosis. 2019 May;284:11-17. doi: 10.1016/j.atherosclerosis.2019.02.012. Epub 2019 Feb 22.
195 Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial.Lancet Diabetes Endocrinol. 2017 Nov;5(11):877-886. doi: 10.1016/S2213-8587(17)30309-1. Epub 2017 Sep 13.
196 Association of MMP-1 (rs1799750)-1607 2G/2G and MMP-3 (rs3025058)-1612 6A/6A Genotypes With Coronary Artery Disease Risk Among Iranian Turks.J Cardiovasc Pharmacol. 2019 Nov;74(5):420-425. doi: 10.1097/FJC.0000000000000727.
197 Matrix metalloproteinase-1 and matrix metalloproteinase-12 gene polymorphisms and the outcome of coronary artery disease.Coron Artery Dis. 2011;22(6):388-93. doi: 10.1097/MCA.0b013e3283478d40.
198 Matrix metalloproteinase-8 and tissue inhibitor of matrix metalloproteinase-1 predict incident cardiovascular disease events and all-cause mortality in a population-based cohort.Eur J Prev Cardiol. 2017 Jul;24(11):1136-1144. doi: 10.1177/2047487317706585. Epub 2017 Apr 21.
199 The 2756A>G variant in the gene encoding methionine synthase: its relation with plasma homocysteine levels and risk of coronary heart disease in a Dutch case-control study.Thromb Res. 2003 May 1;110(2-3):87-91. doi: 10.1016/s0049-3848(03)00341-4.
200 Association of a microsomal triglyceride transfer protein gene polymorphism with blood pressure in Japanese women.Int J Mol Med. 2006 Jan;17(1):83-8.
201 -5 Fatty Acid Desaturase FADS1 Impacts Metabolic Disease by Balancing Proinflammatory and Proresolving Lipid Mediators.Arterioscler Thromb Vasc Biol. 2018 Jan;38(1):218-231. doi: 10.1161/ATVBAHA.117.309660. Epub 2017 Oct 26.
202 Association of circulating levels of nicotinamide phosphoribosyltransferase (NAMPT/Visfatin) and of a frequent polymorphism in the promoter of the NAMPT gene with coronary artery disease in diabetic and non-diabetic subjects.Cardiovasc Diabetol. 2013 Aug 22;12:119. doi: 10.1186/1475-2840-12-119.
203 Mechanisms of Niemann-Pick type C1 Like 1 protein degradation in intestinal epithelial cells.Am J Physiol Cell Physiol. 2019 Apr 1;316(4):C559-C566. doi: 10.1152/ajpcell.00465.2018. Epub 2019 Feb 21.
204 NPR-C gene polymorphism is associated with increased susceptibility to coronary artery disease in Chinese Han population: a multicenter study.Oncotarget. 2016 Jun 7;7(23):33662-74. doi: 10.18632/oncotarget.9358.
205 Effects of neuropeptide Y on coronary artery vasomotion in patients with microvascular angina.Int J Cardiol. 2017 Jul 1;238:123-127. doi: 10.1016/j.ijcard.2017.03.024. Epub 2017 Mar 16.
206 Association of Circulating Neuregulin-4 with Presence and Severity of Coronary Artery Disease.Int Heart J. 2019 Jan 25;60(1):45-49. doi: 10.1536/ihj.18-130. Epub 2018 Nov 5.
207 Netrin-1 is associated with macrophage infiltration and polarization in human epicardial adipose tissue in coronary artery disease.J Cardiol. 2017 Jun;69(6):851-858. doi: 10.1016/j.jjcc.2016.08.016. Epub 2016 Oct 7.
208 Low-dose daily aspirin reduces topical minoxidil efficacy in androgenetic alopecia patients.Dermatol Ther. 2018 Nov;31(6):e12741. doi: 10.1111/dth.12741. Epub 2018 Oct 8.
209 Clopidogrel resistance in North Indian patients of coronary artery disease and lack of its association with platelet ADP receptors P2Y1 and P2Y12 gene polymorphisms.Platelets. 2013;24(4):297-302. doi: 10.3109/09537104.2012.693992. Epub 2012 Jun 21.
210 Analysis of predicted loss-of-function variants in UK Biobank identifies variants protective for disease.Nat Commun. 2018 Apr 24;9(1):1613. doi: 10.1038/s41467-018-03911-8.
211 Association of PECAM-1 Gene Polymorphisms with Kawasaki Disease in Chinese Children.Dis Markers. 2017;2017:2960502. doi: 10.1155/2017/2960502. Epub 2017 Apr 23.
212 Association between serum lipoprotein-associated phospholipase A2, ischemic modified albumin and acute coronary syndrome: a cross-sectional study.Heart Vessels. 2019 Oct;34(10):1608-1614. doi: 10.1007/s00380-019-01403-3. Epub 2019 Apr 8.
213 Identification of novel serum markers for the progression of coronary atherosclerosis in WHHLMI rabbits, an animal model of familial hypercholesterolemia.Atherosclerosis. 2019 May;284:18-23. doi: 10.1016/j.atherosclerosis.2019.02.020. Epub 2019 Feb 28.
214 Plasma phospholipid transfer protein activity is decreased in type 2 diabetes during treatment with atorvastatin: a role for apolipoprotein E?.Diabetes. 2006 May;55(5):1491-6. doi: 10.2337/db05-1685.
215 Nrf2, NF-B and PPAR/ mRNA Expression Profile in Patients with Coronary Artery Disease.Arq Bras Cardiol. 2019 Dec;113(6):1121-1127. doi: 10.5935/abc.20190125.
216 Mitochondrial permeability transition in cardiac ischemia-reperfusion: whether cyclophilin D is a viable target for cardioprotection?.Cell Mol Life Sci. 2017 Aug;74(15):2795-2813. doi: 10.1007/s00018-017-2502-4. Epub 2017 Apr 4.
217 Protein kinase C expression in platelets from patients with acute myocardial infarction.PLoS One. 2012;7(10):e46409. doi: 10.1371/journal.pone.0046409. Epub 2012 Oct 5.
218 Predicting significance of COX-2 expression of peripheral blood monocyte in patients with coronary artery disease.Ann Transl Med. 2019 Sep;7(18):483. doi: 10.21037/atm.2019.08.75.
219 Rare SCARB1 mutations associate with high-density lipoprotein cholesterol but not with coronary artery disease.Eur Heart J. 2018 Jun 14;39(23):2172-2178. doi: 10.1093/eurheartj/ehy169.
220 Late sodium current associated cardiac electrophysiological and mechanical dysfunction.Pflugers Arch. 2018 Mar;470(3):461-469. doi: 10.1007/s00424-017-2079-7. Epub 2017 Nov 10.
221 Toll-Like Receptor induced CD11b and L-selectin response in patients with coronary artery disease.PLoS One. 2013;8(4):e60467. doi: 10.1371/journal.pone.0060467. Epub 2013 Apr 3.
222 SELP genetic polymorphisms may contribute to the pathogenesis of coronary heart disease and myocardial infarction: a meta-analysis.Mol Biol Rep. 2014 May;41(5):3369-80. doi: 10.1007/s11033-014-3199-1. Epub 2014 Feb 7.
223 PEDF increases GLUT4-mediated glucose uptake in rat ischemic myocardium via PI3K/AKT pathway in a PEDFR-dependent manner.Int J Cardiol. 2019 May 15;283:136-143. doi: 10.1016/j.ijcard.2019.02.035. Epub 2019 Feb 21.
224 Heat shock protein 47 is expressed in fibrous regions of human atheroma and Is regulated by growth factors and oxidized low-density lipoprotein.Circulation. 2000 Mar 21;101(11):1229-33. doi: 10.1161/01.cir.101.11.1229.
225 Knockdown of Sfrp4 attenuates apoptosis to protect against myocardial ischemia/reperfusion injury.J Pharmacol Sci. 2019 May;140(1):14-19. doi: 10.1016/j.jphs.2019.04.003. Epub 2019 Apr 29.
226 Role of SH2B3 R262W gene polymorphism and risk of coronary heart disease: A PRISMA-compliant meta-analysis.Medicine (Baltimore). 2018 Nov;97(48):e13436. doi: 10.1097/MD.0000000000013436.
227 Impaired renal organic anion transport 1 (SLC22A6) and its regulation following acute myocardial infarction and reperfusion injury in rats.Biochim Biophys Acta Mol Basis Dis. 2019 Sep 1;1865(9):2342-2355. doi: 10.1016/j.bbadis.2019.05.013. Epub 2019 May 21.
228 Associations of the uric acid related genetic variants in SLC2A9 and ABCG2 loci with coronary heart disease risk.BMC Genet. 2015 Jan 30;16(1):4. doi: 10.1186/s12863-015-0162-7.
229 Inhibition of Sodium Glucose Cotransporters Improves Cardiac Performance.Int J Mol Sci. 2019 Jul 4;20(13):3289. doi: 10.3390/ijms20133289.
230 SLCO1B1 521T > C polymorphism associated with rosuvastatin-induced myotoxicity in Chinese coronary artery disease patients: a nested case-control study. Eur J Clin Pharmacol. 2017 Nov;73(11):1409-1416.
231 Acyl-CoA: cholesterol acyltransferase-2 gene polymorphisms and their association with plasma lipids and coronary artery disease risks.Hum Genet. 2005 Dec;118(3-4):393-403. doi: 10.1007/s00439-005-0055-3. Epub 2005 Sep 30.
232 Sortilin levels are associated with peripheral arterial disease in type 2 diabetic subjects.Cardiovasc Diabetol. 2019 Jan 11;18(1):5. doi: 10.1186/s12933-019-0805-5.
233 Expression of Sterol Regulatory Element-Binding Proteins in epicardial adipose tissue in patients with coronary artery disease and diabetes mellitus: preliminary study.Int J Med Sci. 2017 Feb 23;14(3):268-274. doi: 10.7150/ijms.17821. eCollection 2017.
234 The association between serum serglycin level and coronary artery disease severity in patients with stable angina pectoris.Kardiol Pol. 2018;76(4):783-790. doi: 10.5603/KP.2018.0007. Epub 2018 Jan 9.
235 Expression of telomere repeat binding factor 1 and TRF2 in Alzheimer's disease and correlation with clinical parameters.Neurol Res. 2019 Jun;41(6):504-509. doi: 10.1080/01616412.2019.1580456. Epub 2019 Feb 14.
236 Sequence variation in telomerase reverse transcriptase (TERT) as a determinant of risk of cardiovascular disease: the Atherosclerosis Risk in Communities (ARIC) study.BMC Med Genet. 2015 Jul 23;16:52. doi: 10.1186/s12881-015-0194-x.
237 Significant genetic association of a functional TFPI variant with circulating fibrinogen levels and coronary artery disease.Mol Genet Genomics. 2018 Feb;293(1):119-128. doi: 10.1007/s00438-017-1365-6. Epub 2017 Sep 11.
238 Thrombopoietin and platelet aggregation in patients with stable coronary artery disease.Platelets. 2017 Dec;28(8):822-824. doi: 10.1080/09537104.2017.1296567. Epub 2017 Apr 24.
239 Epigenetic modulation of tenascin C in the heart: implications on myocardial ischemia, hypertrophy and metabolism.J Hypertens. 2019 Sep;37(9):1861-1870. doi: 10.1097/HJH.0000000000002097.
240 10-Year Associations Between Tumor Necrosis Factor Receptors 1 and 2 and Cardiovascular Events in Patients With Stable Coronary Heart Disease: A CLARICOR (Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease) Trial Substudy.J Am Heart Assoc. 2018 Apr 23;7(9):e008299. doi: 10.1161/JAHA.117.008299.
241 Circulating TNFSF14 (Tumor Necrosis Factor Superfamily 14) Predicts Clinical Outcome in Patients With Stable Coronary Artery Disease.Arterioscler Thromb Vasc Biol. 2019 Jun;39(6):1240-1252. doi: 10.1161/ATVBAHA.118.312166.
242 Inhibition of MicroRNA-206 Ameliorates Ischemia-Reperfusion Arrhythmia in a Mouse Model by Targeting Connexin43.J Cardiovasc Transl Res. 2020 Aug;13(4):584-592. doi: 10.1007/s12265-019-09940-y. Epub 2019 Dec 2.
243 Postmortem IgE determination in coronary artery disease.J Forensic Leg Med. 2019 Feb;62:1-6. doi: 10.1016/j.jflm.2018.12.006. Epub 2018 Dec 24.
244 miR-146a polymorphism influences levels of miR-146a, IRAK-1, and TRAF-6 in young patients with coronary artery disease.Cell Biochem Biophys. 2014 Mar;68(2):259-66. doi: 10.1007/s12013-013-9704-7.
245 Melatonin rescues cardiac thioredoxin system during ischemia-reperfusion injury in acute hyperglycemic state by restoring Notch1/Hes1/Akt signaling in a membrane receptor-dependent manner.J Pineal Res. 2017 Jan;62(1). doi: 10.1111/jpi.12375. Epub 2016 Nov 9.
246 The Emerging Role of Thioredoxin-Interacting Protein in Myocardial Ischemia/Reperfusion Injury.J Cardiovasc Pharmacol Ther. 2017 May;22(3):219-229. doi: 10.1177/1074248416675731. Epub 2016 Nov 2.
247 Expression of epicardial adipose tissue thermogenic genes in patients with reduced and preserved ejection fraction heart failure.Int J Med Sci. 2017 Jul 20;14(9):891-895. doi: 10.7150/ijms.19854. eCollection 2017.
248 Atorvastatin Attenuates Metabolic Remodeling in Ischemic Myocardium through the Downregulation of UCP2 Expression.Int J Med Sci. 2018 Mar 8;15(5):517-527. doi: 10.7150/ijms.22454. eCollection 2018.
249 Urotensin-II and cardiovascular remodeling.Peptides. 2008 May;29(5):764-9. doi: 10.1016/j.peptides.2007.09.012. Epub 2007 Sep 29.
250 Urotensin II receptor expression in human right atrium and aorta: effects of ischaemic heart disease.Br J Anaesth. 2009 Apr;102(4):477-84. doi: 10.1093/bja/aep011. Epub 2009 Mar 3.
251 Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation.Circulation. 2010 Oct 26;122(17):1725-33. doi: 10.1161/CIRCULATIONAHA.110.957332. Epub 2010 Oct 11.
252 VEGF-C Gene Polymorphisms Increase Susceptibility to Rheumatoid Arthritis.Int J Med Sci. 2019 Sep 20;16(10):1397-1403. doi: 10.7150/ijms.34659. eCollection 2019.
253 A novel circRNA-miRNA-mRNA network identifies circ-YOD1 as a biomarker for coronary artery disease.Sci Rep. 2019 Dec 4;9(1):18314. doi: 10.1038/s41598-019-54603-2.
254 Functional Relevance of the Anaphylatoxin Receptor C3aR for Platelet Function and Arterial Thrombus Formation Marks an Intersection Point Between Innate Immunity and Thrombosis.Circulation. 2018 Oct 16;138(16):1720-1735. doi: 10.1161/CIRCULATIONAHA.118.034600.
255 -Phthalimidoalkyl Aryl Ureas as Potent and Selective Inhibitors of Cholesterol Esterase.ChemMedChem. 2018 Sep 6;13(17):1833-1847. doi: 10.1002/cmdc.201800388. Epub 2018 Aug 13.
256 Genetic Regulation of the Thymic Stromal Lymphopoietin (TSLP)/TSLP Receptor (TSLPR) Gene Expression and Influence of Epistatic Interactions Between IL-33 and the TSLP/TSLPR Axis on Risk of Coronary Artery Disease.Front Immunol. 2018 Aug 3;9:1775. doi: 10.3389/fimmu.2018.01775. eCollection 2018.
257 Altered human neutrophil FcRI and FcRIII but not FcRII expression is associated with the acute coronary event in patients with coronary artery disease.Coron Artery Dis. 2017 Jan;28(1):63-69. doi: 10.1097/MCA.0000000000000425.
258 Age-Biomarkers-Clinical Risk Factors for Prediction of Cardiovascular Events in Patients With Coronary Artery Disease.Arterioscler Thromb Vasc Biol. 2018 Oct;38(10):2519-2527. doi: 10.1161/ATVBAHA.118.311726.
259 Association of Serum HMGB2 Levels With In-Stent Restenosis: HMGB2 Promotes Neointimal Hyperplasia in Mice With Femoral Artery Injury and Proliferation and Migration of VSMCs.Arterioscler Thromb Vasc Biol. 2017 Apr;37(4):717-729. doi: 10.1161/ATVBAHA.116.308210. Epub 2017 Feb 9.
260 The relationship between insulin resistance, adiponectin and C-reactive protein and vascular endothelial injury in diabetic patients with coronary heart disease.Exp Ther Med. 2018 Sep;16(3):2022-2026. doi: 10.3892/etm.2018.6407. Epub 2018 Jul 4.
261 Association of platelet-activating factor receptor gene rs5938 (G/T) and rs313152 (T/C) polymorphisms with coronary heart disease and blood stasis syndrome in a Chinese Han population.Chin J Integr Med. 2017 Dec;23(12):893-900. doi: 10.1007/s11655-017-2802-4. Epub 2017 Feb 15.
262 Novel epigenetic-sensitive clinical challenges both in type 1 and type 2 diabetes.J Diabetes Complications. 2018 Nov;32(11):1076-1084. doi: 10.1016/j.jdiacomp.2018.08.012. Epub 2018 Aug 19.
263 B Cell-Activating Factor Neutralization Aggravates Atherosclerosis.Circulation. 2018 Nov 13;138(20):2263-2273. doi: 10.1161/CIRCULATIONAHA.117.032790.
264 Association of common polymorphisms in GLUT9 gene with gout but not with coronary artery disease in a large case-control study.PLoS One. 2008 Apr 9;3(4):e1948. doi: 10.1371/journal.pone.0001948.
265 Genome-wide interaction-based association analysis identified multiple new susceptibility Loci for common diseases.PLoS Genet. 2011 Mar;7(3):e1001338. doi: 10.1371/journal.pgen.1001338. Epub 2011 Mar 17.
266 Pathogenic variants in the ABCC6 gene are associated with an increased risk for ischemic stroke.Brain Pathol. 2018 Nov;28(6):822-831. doi: 10.1111/bpa.12620.
267 Association of ATP2B1 common variants with asymptomatic intracranial and extracranial large artery stenosis in hypertension patients.Clin Exp Hypertens. 2019;41(4):323-329. doi: 10.1080/10641963.2018.1481421. Epub 2018 Jun 14.
268 Alcohol dehydrogenase type 1C (ADH1C) variants, alcohol consumption traits, HDL-cholesterol and risk of coronary heart disease in women and men: British Women's Heart and Health Study and Caerphilly cohorts.Atherosclerosis. 2008 Feb;196(2):871-8. doi: 10.1016/j.atherosclerosis.2007.02.002. Epub 2007 Mar 26.
269 Mutation in CYP27A1 identified in family with coronary artery disease.Eur J Med Genet. 2013 Dec;56(12):655-60. doi: 10.1016/j.ejmg.2013.09.008. Epub 2013 Sep 28.
270 The roles of cytochrome p450 in ischemic heart disease.Curr Drug Metab. 2011 Jul;12(6):526-32. doi: 10.2174/138920011795713715.
271 AGXT2 and DDAH-1 genetic variants are highly correlated with serum ADMA and SDMA levels and with incidence of coronary artery disease in Egyptians.Mol Biol Rep. 2018 Dec;45(6):2411-2419. doi: 10.1007/s11033-018-4407-1. Epub 2018 Oct 3.
272 Methionine sulfoxide reductase A rs10903323 G/A polymorphism is associated with increased risk of coronary artery disease in a Chinese population.Clin Biochem. 2013 Nov;46(16-17):1668-72. doi: 10.1016/j.clinbiochem.2013.07.011. Epub 2013 Jul 21.
273 Gene-gene interaction between PPARG and CYP1A1 gene on coronary artery disease in the Chinese Han Population.Oncotarget. 2017 May 23;8(21):34398-34404. doi: 10.18632/oncotarget.16186.
274 PON2 and PPARG polymorphisms as biomarkers of risk for coronary heart disease.Biomark Med. 2018 Mar;12(3):287-297. doi: 10.2217/bmm-2017-0227. Epub 2018 Feb 14.
275 Paraoxonase 3: Structure and Its Role in Pathophysiology of Coronary Artery Disease.Biomolecules. 2019 Dec 3;9(12):817. doi: 10.3390/biom9120817.
276 Comparison of Outcomes After Percutaneous Coronary Intervention in Elderly Patients, Including 10628 Nonagenarians: Insights From a Japanese Nationwide Registry (J-PCI Registry).J Am Heart Assoc. 2019 Mar 5;8(5):e011183. doi: 10.1161/JAHA.118.011017.
277 Low-level arsenic exposure, AS3MT gene polymorphism and cardiovascular diseases in rural Texas counties.Environ Res. 2012 Feb;113:52-7. doi: 10.1016/j.envres.2012.01.003. Epub 2012 Feb 15.
278 Carotenoid metabolic (BCO1) polymorphisms and personal behaviors modify the risk of coronary atherosclerosis: a nested case-control study in Han Chinese with dyslipidaemia (2013-2016).Asia Pac J Clin Nutr. 2019;28(1):192-202. doi: 10.6133/apjcn.201903_28(1).0025.
279 Mast cell derived carboxypeptidase A3 is decreased among patients with advanced coronary artery disease.Cardiol J. 2019;26(6):680-686. doi: 10.5603/CJ.a2018.0018. Epub 2018 Mar 7.
280 No evidence that genetically reduced 25-hydroxyvitamin D is associated with increased risk of ischaemic heart disease or myocardial infarction: a Mendelian randomization study.Int J Epidemiol. 2015 Apr;44(2):651-61. doi: 10.1093/ije/dyv078. Epub 2015 May 16.
281 Haplotype study of the CYP4A11 gene and coronary artery disease in Han and Uygur populations in China.Gene. 2013 Jan 10;512(2):510-6. doi: 10.1016/j.gene.2012.10.007. Epub 2012 Oct 17.
282 CYP4F2 genetic polymorphisms are associated with coronary heart disease in a Chinese population.Lipids Health Dis. 2014 May 20;13:83. doi: 10.1186/1476-511X-13-83.
283 Interactions Between Regulatory Variants in CYP7A1 (Cholesterol 7-Hydroxylase) Promoter and Enhancer Regions Regulate CYP7A1 Expression.Circ Genom Precis Med. 2018 Oct;11(10):e002082. doi: 10.1161/CIRCGEN.118.002082.
284 Effect of polymorphisms in the NADSYN1/DHCR7 locus (rs12785878 and rs1790349) on plasma 25-hydroxyvitamin D levels and coronary artery disease incidence.J Nutrigenet Nutrigenomics. 2013;6(6):327-35. doi: 10.1159/000360422. Epub 2014 Mar 15.
285 Polymorphism in glutamate-cysteine ligase modifier subunit gene is associated with impairment of nitric oxide-mediated coronary vasomotor function. Circulation. 2003 Sep 23;108(12):1425-7. doi: 10.1161/01.CIR.0000091255.63645.98. Epub 2003 Sep 15.
286 Genetic susceptibility of glutathione S-transferase genes (GSTM1/T1 and P1) to coronary artery disease in Asian Indians.Ann Hum Genet. 2018 Nov;82(6):448-456. doi: 10.1111/ahg.12274. Epub 2018 Jul 24.
287 Coronary microvascular dysfunction in patients with stable coronary artery disease: The CE-MARC 2 coronary physiology sub-study.Int J Cardiol. 2018 Sep 1;266:7-14. doi: 10.1016/j.ijcard.2018.04.061. Epub 2018 Apr 19.
288 Association of N-acetyltransferase-2 polymorphism with an increased risk of coronary heart disease in a Chinese population.Genet Mol Res. 2016 Mar 4;15(1):15016954. doi: 10.4238/gmr.15016954.
289 Serum N(1)-methylnicotinamide is Associated with Left Ventricular Systolic Dysfunction in Chinese.Sci Rep. 2018 Jun 5;8(1):8581. doi: 10.1038/s41598-018-26956-7.
290 Impact of scan quality on the diagnostic performance of CCTA, SPECT, and PET for diagnosing myocardial ischemia defined by fractional flow reserve.J Cardiovasc Comput Tomogr. 2020 Jan-Feb;14(1):60-67. doi: 10.1016/j.jcct.2019.06.007. Epub 2019 Jun 12.
291 Polymorphisms in genes encoding acetylsalicylic acid metabolizing enzymes are unrelated to upper gastrointestinal health in cardiovascular patients on acetylsalicylic acid. Br J Clin Pharmacol. 2005 Dec;60(6):623-8.
292 Serum Tartrate-resistant Acid Phosphatase-5b Levels are Associated with the Severity and Extent of Coronary Atherosclerosis in Patients with Coronary Artery Disease.J Atheroscler Thromb. 2017 Oct 1;24(10):1058-1068. doi: 10.5551/jat.39339. Epub 2017 Apr 19.
293 Regulation of Abro1/KIAA0157 during myocardial infarction and cell death reveals a novel cardioprotective mechanism for Lys63-specific deubiquitination.J Mol Cell Cardiol. 2011 Apr;50(4):652-61. doi: 10.1016/j.yjmcc.2010.12.015. Epub 2010 Dec 30.
294 Genetic variation associated with circulating monocyte count in the eMERGE Network.Hum Mol Genet. 2013 May 15;22(10):2119-27. doi: 10.1093/hmg/ddt010. Epub 2013 Jan 12.
295 Adenosine-to-inosine RNA editing controls cathepsin S expression in atherosclerosis by enabling HuR-mediated post-transcriptional regulation.Nat Med. 2016 Oct;22(10):1140-1150. doi: 10.1038/nm.4172. Epub 2016 Sep 5.
296 Are decreased AdipoR1 mRNA levels associated with adiponectin resistance in coronary artery disease patients?.Clin Exp Pharmacol Physiol. 2015 Apr;42(4):331-6. doi: 10.1111/1440-1681.12361.
297 Integrative analysis of vascular endothelial cell genomic features identifies AIDA as a coronary artery disease candidate gene.Genome Biol. 2019 Jul 8;20(1):133. doi: 10.1186/s13059-019-1749-5.
298 Association of polymorphisms in the ALOX15B gene with coronary artery disease.Clin Biochem. 2014 Apr;47(6):349-55. doi: 10.1016/j.clinbiochem.2013.12.013. Epub 2013 Dec 27.
299 Correlation between angiopoietin-like proteins in inflammatory mediators in peripheral blood and severity of coronary arterial lesion in patients with acute myocardial infarction.Exp Ther Med. 2019 May;17(5):3495-3500. doi: 10.3892/etm.2019.7386. Epub 2019 Mar 13.
300 Isoforms of apolipoprotein C-I associated with individuals with coronary artery disease.Biochem Biophys Res Commun. 2011 Jan 28;404(4):1034-8. doi: 10.1016/j.bbrc.2010.12.105. Epub 2010 Dec 25.
301 Identification of apolipoprotein D as a cardioprotective gene using a mouse model of lethal atherosclerotic coronary artery disease.Proc Natl Acad Sci U S A. 2013 Oct 15;110(42):17023-8. doi: 10.1073/pnas.1315986110. Epub 2013 Sep 30.
302 Genetic variability in adapter proteins with APPL1/2 is associated with the risk of coronary artery disease in type 2 diabetes mellitus in Chinese Han population.Chin Med J (Engl). 2011 Nov;124(22):3618-21.
303 Relationship between Modulator Recognition Factor 2/AT-rich Interaction Domain 5B Gene Variations and Type 2 Diabetes Mellitus or Lipid Metabolism in a Northern Chinese Population.Chin Med J (Engl). 2017 May 5;130(9):1055-1061. doi: 10.4103/0366-6999.204926.
304 Functional Analysis of a Carotid Intima-Media Thickness Locus Implicates BCAR1 and Suggests a Causal Variant.Circ Cardiovasc Genet. 2015 Oct;8(5):696-706. doi: 10.1161/CIRCGENETICS.115.001062. Epub 2015 Aug 14.
305 Lower serum osteocalcin concentrations in patients with type 2 diabetes and relationships with vascular risk factors among patients with coronary artery disease.J Diabetes Complications. 2019 May;33(5):390-397. doi: 10.1016/j.jdiacomp.2019.01.003. Epub 2019 Jan 17.
306 Folate gene polymorphisms MTR A2756G, MTRR A66G, and BHMT G742A and risk for coronary artery disease: a meta-analysis.Genet Test Mol Biomarkers. 2012 Jun;16(6):471-5. doi: 10.1089/gtmb.2011.0237. Epub 2012 Feb 17.
307 The relationships between FAM5C SNP (rs10920501) variability and metabolic syndrome and inflammation in women with coronary heart disease.Biol Res Nurs. 2013 Apr;15(2):160-6. doi: 10.1177/1099800411424487. Epub 2011 Oct 18.
308 Association of a polymorphism of BTN2A1 with dyslipidemia in community-dwelling individuals.Mol Med Rep. 2014 Mar;9(3):808-12. doi: 10.3892/mmr.2014.1902. Epub 2014 Jan 16.
309 Impact of gender and age on the association of the BUD13-ZNF259 rs964184 polymorphism with coronary heart disease.Anatol J Cardiol. 2018 Jan;19(1):42-49. doi: 10.14744/AnatolJCardiol.2017.8002.
310 A Single-Nucleotide Polymorphism in C12orf43 Region is Associated with the Risk of Coronary Artery Disease in a Pakistani Cohort.Biochem Genet. 2016 Oct;54(5):676-84. doi: 10.1007/s10528-016-9746-9. Epub 2016 Jun 4.
311 CTRP13 inhibits atherosclerosis via autophagy-lysosome-dependent degradation of CD36.FASEB J. 2019 Feb;33(2):2290-2300. doi: 10.1096/fj.201801267RR. Epub 2018 Sep 17.
312 Association of adenylate cyclase-associated protein 1 with coronary artery disease.Eur J Clin Invest. 2017 Sep;47(9):659-666. doi: 10.1111/eci.12787. Epub 2017 Aug 4.
313 Genetic analysis in UK Biobank links insulin resistance and transendothelial migration pathways to coronary artery disease.Nat Genet. 2017 Sep;49(9):1392-1397. doi: 10.1038/ng.3914. Epub 2017 Jul 17.
314 Contribution of homeostatic chemokines CCL19 and CCL21 and their receptor CCR7 to coronary artery disease.Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):1933-41. doi: 10.1161/ATVBAHA.113.303081. Epub 2014 Jul 2.
315 Plasma CD93 concentration is a potential novel biomarker for coronary artery disease.J Intern Med. 2011 Sep;270(3):229-36. doi: 10.1111/j.1365-2796.2011.02364.x. Epub 2011 Mar 21.
316 High serum YKL-40 level positively correlates with coronary artery disease.Biomark Med. 2017 Feb;11(2):133-139. doi: 10.2217/bmm-2016-0240. Epub 2017 Jan 18.
317 Validation of aspirin response-related transcripts in patients with coronary artery disease and preliminary investigation on CMTM5 function.Gene. 2017 Aug 15;624:56-65. doi: 10.1016/j.gene.2017.04.041. Epub 2017 Apr 28.
318 Associations of the SREBP-1c gene polymorphism with gender-specific changes in serum lipids induced by a high-carbohydrate diet in healthy Chinese youth.Appl Physiol Nutr Metab. 2011 Apr;36(2):226-32. doi: 10.1139/h11-005.
319 Altered serum level of cartilage oligomeric matrix protein and its association with coronary calcification in patients with coronary heart disease.J Geriatr Cardiol. 2017 Feb;14(2):87-92. doi: 10.11909/j.issn.1671-5411.2017.02.002.
320 Cortistatin inhibits migration and proliferation of human vascular smooth muscle cells and decreases neointimal formation on carotid artery ligation.Circ Res. 2013 May 24;112(11):1444-55. doi: 10.1161/CIRCRESAHA.112.300695. Epub 2013 Apr 17.
321 Lack of association between cellular repressor of E1A-stimulated genes (CREG) [corrected] polymorphisms and coronary artery disease in the Han population of North China.Clin Chim Acta. 2011 Jan 30;412(3-4):249-52. doi: 10.1016/j.cca.2010.10.008. Epub 2010 Oct 15.
322 Clinical Evidence Supports a Protective Role for CXCL5 in Coronary Artery Disease.Am J Pathol. 2017 Dec;187(12):2895-2911. doi: 10.1016/j.ajpath.2017.08.006. Epub 2017 Nov 16.
323 Association of nicotinamide adenine dinucleotide phosphate oxidase p22phox gene 549C>T polymorphism with coronary artery disease.Chin Med J (Engl). 2012 Apr;125(8):1416-9.
324 Association in a Chinese population of a genetic variation in the early B-cell factor 1 gene with coronary artery disease.BMC Cardiovasc Disord. 2017 Feb 10;17(1):57. doi: 10.1186/s12872-017-0489-2.
325 Association of Egr3 genetic polymorphisms and coronary artery disease in the Uygur and Han of China.Lipids Health Dis. 2014 May 21;13:84. doi: 10.1186/1476-511X-13-84.
326 Genetics of diabetes complications.Curr Diab Rep. 2010 Dec;10(6):467-75. doi: 10.1007/s11892-010-0147-x.
327 Adropin: Connection between Nonalcoholic Fatty Liver Disease and Coronary Artery Disease.Med Princ Pract. 2020;29(1):97. doi: 10.1159/000502039. Epub 2019 Jul 11.
328 Fine mapping of chromosome 3q22.3 identifies two haplotype blocks in ESYT3 associated with coronary artery disease in female Han Chinese.Atherosclerosis. 2011 Oct;218(2):397-403. doi: 10.1016/j.atherosclerosis.2011.06.017. Epub 2011 Jun 17.
329 Interactions between the APOA5 -1131T>C and the FEN1 10154G>T polymorphisms on 6 polyunsaturated fatty acids in serum phospholipids and coronary artery disease.J Lipid Res. 2010 Nov;51(11):3281-8. doi: 10.1194/jlr.M010330. Epub 2010 Aug 27.
330 Flotillin-2 Gene Is Associated with Coronary Artery Disease in Chinese Han Population.Genet Test Mol Biomarkers. 2015 Dec;19(12):679-83. doi: 10.1089/gtmb.2015.0121. Epub 2015 Nov 10.
331 Insulin Resistance and Future Cognitive Performance and Cognitive Decline inElderly Patients with Cardiovascular Disease.J Alzheimers Dis. 2017;57(2):633-643. doi: 10.3233/JAD-161016.
332 Common variants in CASQ2, GPD1L, and NOS1AP are significantly associated with risk of sudden death in patients with coronary artery disease.Circ Cardiovasc Genet. 2011 Aug 1;4(4):397-402. doi: 10.1161/CIRCGENETICS.111.959916. Epub 2011 Jun 17.
333 Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor.J Clin Invest. 1995 Aug;96(2):741-50. doi: 10.1172/JCI118118.
334 MnSOD, CAT and GPx-3 genetic polymorphisms in coronary artery disease.Mol Biol Rep. 2019 Feb;46(1):841-845. doi: 10.1007/s11033-018-4539-3. Epub 2019 Jan 2.
335 G protein receptor kinase 4 polymorphisms: -blocker pharmacogenetics and treatment-related outcomes in hypertension.Hypertension. 2012 Oct;60(4):957-64. doi: 10.1161/HYPERTENSIONAHA.112.198721. Epub 2012 Sep 4.
336 Glutathione S-transferase M1 polymorphism and coronary heart disease susceptibility: a meta-analysis involving 47,596 subjects.Heart Lung Circ. 2014 Jun;23(6):578-85. doi: 10.1016/j.hlc.2014.01.003. Epub 2014 Jan 22.
337 Association of the coronary artery disease risk gene GUCY1A3 with ischaemic events after coronary intervention.Cardiovasc Res. 2019 Aug 1;115(10):1512-1518. doi: 10.1093/cvr/cvz015.
338 A HAND to TBX5 Explains the Link Between Thalidomide and Cardiac Diseases.Sci Rep. 2017 May 3;7(1):1416. doi: 10.1038/s41598-017-01641-3.
339 Polymorphisms of human platelet alloantigens HPA-1 and HPA-2 associated with severe coronary artery disease.Cardiovasc Pathol. 2010 Sep-Oct;19(5):302-7. doi: 10.1016/j.carpath.2009.04.003. Epub 2009 Jun 9.
340 Association of heat shock protein70-2 (HSP70-2) gene polymorphism with coronary artery disease in an Iranian population.Gene. 2014 Oct 25;550(2):180-4. doi: 10.1016/j.gene.2014.08.012. Epub 2014 Aug 7.
341 IRF2BP2 Reduces Macrophage Inflammation and Susceptibility to Atherosclerosis.Circ Res. 2015 Sep 25;117(8):671-83. doi: 10.1161/CIRCRESAHA.114.305777. Epub 2015 Jul 20.
342 Joint analysis of left ventricular expression and circulating plasma levels of Omentin after myocardial ischemia.Cardiovasc Diabetol. 2017 Jul 7;16(1):87. doi: 10.1186/s12933-017-0567-x.
343 Association of KCTD10, MVK, and MMAB polymorphisms with dyslipidemia and coronary heart disease in Han Chinese population.Lipids Health Dis. 2016 Oct 4;15(1):171. doi: 10.1186/s12944-016-0348-7.
344 Tetra primer ARMS-PCR relates folate/homocysteine pathway genes and ACE gene polymorphism with coronary artery disease.Mol Cell Biochem. 2011 Sep;355(1-2):289-97. doi: 10.1007/s11010-011-0866-6. Epub 2011 May 13.
345 Impact of KIF6 Polymorphism rs20455 on Coronary Heart Disease Risk and Effectiveness of Statin Therapy in 100 Patients from Southern Iran.Arch Iran Med. 2015 Oct;18(10):683-7.
346 Genome-wide DNA methylation encodes cardiac transcriptional reprogramming in human ischemic heart failure.Lab Invest. 2019 Mar;99(3):371-386. doi: 10.1038/s41374-018-0104-x. Epub 2018 Aug 8.
347 Expression of Mac-2 binding protein in human carotid atheroma is associated with plaque instability and clinical manifestations.Biomed Pharmacother. 2019 Feb;110:465-472. doi: 10.1016/j.biopha.2018.12.015. Epub 2018 Dec 6.
348 Successful percutaneous coronary intervention in a patient with combined deficiency of FV and FVIII due to novel compound heterozygous mutations in LMAN1.Haemophilia. 2013 Jul;19(4):607-10. doi: 10.1111/hae.12128. Epub 2013 Apr 5.
349 A novel molecular diagnostic marker for familial and early-onset coronary artery disease and myocardial infarction in the LRP8 gene.Circ Cardiovasc Genet. 2014 Aug;7(4):514-20. doi: 10.1161/CIRCGENETICS.113.000321. Epub 2014 May 27.
350 MADD-FOLH1 Polymorphisms and Their Haplotypes with Serum Lipid Levels and the Risk of Coronary Heart Disease and Ischemic Stroke in a Chinese Han Population.Nutrients. 2016 Apr 8;8(4):208. doi: 10.3390/nu8040208.
351 Association of polymorphisms in the MAFB gene and the risk of coronary artery disease and ischemic stroke: a case-control study.Lipids Health Dis. 2015 Jul 25;14:79. doi: 10.1186/s12944-015-0078-2.
352 Association between TNIP1, MPHOSPH6 and ZNF208 genetic polymorphisms and the coronary artery disease risk in Chinese Han population.Oncotarget. 2017 Aug 24;8(44):77233-77240. doi: 10.18632/oncotarget.20432. eCollection 2017 Sep 29.
353 Novel genes in LDL metabolism--a comprehensive overview.Curr Opin Lipidol. 2015 Jun;26(3):179-87. doi: 10.1097/MOL.0000000000000175.
354 Genome-wide association analysis identifies TYW3/CRYZ and NDST4 loci associated with circulating resistin levels.Hum Mol Genet. 2012 Nov 1;21(21):4774-80. doi: 10.1093/hmg/dds300. Epub 2012 Jul 26.
355 p53 codon 72 polymorphism and coronary artery disease: evidence of interaction with ACP?"Gloria-Bottini F. Saccucci P
356 Long noncoding RNA NEXN-AS1 mitigates atherosclerosis by regulating the actin-binding protein NEXN.J Clin Invest. 2019 Mar 1;129(3):1115-1128. doi: 10.1172/JCI98230. Epub 2019 Feb 4.
357 Cost-effectiveness of coronary artery bypass graft and percutaneous coronary intervention compared to medical therapy in patients with coronary artery disease: a systematic review.Heart Fail Rev. 2019 Nov;24(6):967-975. doi: 10.1007/s10741-019-09811-3.
358 Regulation of NADPH oxidase 5 by protein kinase C isoforms.PLoS One. 2014 Feb 5;9(2):e88405. doi: 10.1371/journal.pone.0088405. eCollection 2014.
359 The impact of OGG1, MTH1 and MnSOD gene polymorphisms on 8-hydroxy-2'-deoxyguanosine and cellular superoxide dismutase activity in myocardial ischemia-reperfusion.Mol Biol Rep. 2011 Apr;38(4):2427-35. doi: 10.1007/s11033-010-0378-6. Epub 2010 Nov 21.
360 Estimating haplotype effects for survival data.Biometrics. 2010 Sep;66(3):705-15. doi: 10.1111/j.1541-0420.2009.01329.x.
361 Intense Light-Mediated Circadian Cardioprotection via Transcriptional Reprogramming of the Endothelium.Cell Rep. 2019 Aug 6;28(6):1471-1484.e11. doi: 10.1016/j.celrep.2019.07.020.
362 PF-4var/CXCL4L1 predicts outcome in stable coronary artery disease patients with preserved left ventricular function.PLoS One. 2012;7(2):e31343. doi: 10.1371/journal.pone.0031343. Epub 2012 Feb 23.
363 PLA2G10 Gene Variants, sPLA2 Activity, and Coronary Heart Disease Risk.Circ Cardiovasc Genet. 2015 Apr;8(2):356-62. doi: 10.1161/CIRCGENETICS.114.000633. Epub 2015 Jan 12.
364 Deciphering the Causal Role of sPLA2s and Lp-PLA2 in Coronary Heart Disease.Arterioscler Thromb Vasc Biol. 2015 Nov;35(11):2281-9. doi: 10.1161/ATVBAHA.115.305234. Epub 2015 Sep 3.
365 Genome-wide association analysis of imputed rare variants: application to seven common complex diseases.Genet Epidemiol. 2012 Dec;36(8):785-96. doi: 10.1002/gepi.21675. Epub 2012 Sep 5.
366 Haplotypes encompassing the KIAA0391 and PSMA6 gene cluster confer a genetic link for myocardial infarction and coronary artery disease.Ann Hum Genet. 2009 Sep;73(Pt 5):475-83. doi: 10.1111/j.1469-1809.2009.00534.x. Epub 2009 Jun 16.
367 ScaI atrial natriuretic peptide gene polymorphisms and their possible association with postoperative atrial fibrillation - a preliminary report.Arch Med Sci. 2017 Apr 1;13(3):568-574. doi: 10.5114/aoms.2016.58270. Epub 2016 May 12.
368 Association of vaspin gene polymorphisms with coronary artery disease in Chinese population and function study.Clin Chim Acta. 2013 Jan 16;415:233-8. doi: 10.1016/j.cca.2012.10.042. Epub 2012 Oct 31.
369 Variant of PAI-2 gene is associated with coronary artery disease and recurrent coronary event risk in Chinese Han population.Lipids Health Dis. 2015 Nov 16;14:148. doi: 10.1186/s12944-015-0150-y.
370 Peripheral leucocytes and tissue gene expression of granzyme B/perforin system and serpinB9: Impact on inflammation and insulin resistance in coronary atherosclerosis.Diabetes Res Clin Pract. 2017 Sep;131:132-141. doi: 10.1016/j.diabres.2017.07.013. Epub 2017 Jul 12.
371 SBP above 180mmHg at moderate exercise workload increases coronary heart disease risk in healthy men during 28-year follow-up.J Hypertens. 2019 May;37(5):949-955. doi: 10.1097/HJH.0000000000001959.
372 Siglec-1 on monocytes is a potential risk marker for monitoring disease severity in coronary artery disease.Clin Biochem. 2009 Jul;42(10-11):1057-63. doi: 10.1016/j.clinbiochem.2009.02.026. Epub 2009 Mar 13.
373 Corrigendum to "Circulating Levels of Sirtuin 4, a Potential Marker of Oxidative Metabolism, Related to Coronary Artery Disease in Obese Patients Suffering from NAFLD, with Normal or Slightly Increased Liver Enzymes".Oxid Med Cell Longev. 2018 Aug 13;2018:6357164. doi: 10.1155/2018/6357164. eCollection 2018.
374 SOD3 R231G polymorphism associated with coronary artery disease and myocardial infarction. The Ludwigshafen Risk and Cardiovascular Health (LURIC) study.Free Radic Res. 2009 Jul;43(7):677-84. doi: 10.1080/10715760902991763.
375 Mutation in ST6GALNAC5 identified in family with coronary artery disease.Sci Rep. 2014 Jan 8;4:3595. doi: 10.1038/srep03595.
376 Association of TERC and OBFC1 haplotypes with mean leukocyte telomere length and risk for coronary heart disease.PLoS One. 2013 Dec 12;8(12):e83122. doi: 10.1371/journal.pone.0083122. eCollection 2013.
377 SUMO4 Met55Val polymorphism is associated with coronary heart disease in Japanese type 2 diabetes individuals.Diabetes Res Clin Pract. 2009 Jul;85(1):85-9. doi: 10.1016/j.diabres.2009.04.001. Epub 2009 May 1.
378 Polymorphisms in transcobalamin II gene is associated with coronary artery disease in Indian population.Biomarkers. 2012 Mar;17(2):119-24. doi: 10.3109/1354750X.2011.642408. Epub 2011 Dec 22.
379 Comparative gene expression analysis between coronary arteries and internal mammary arteries identifies a role for the TES gene in endothelial cell functions relevant to coronary artery disease.Hum Mol Genet. 2012 Mar 15;21(6):1364-73. doi: 10.1093/hmg/ddr574. Epub 2011 Dec 12.
380 The transcription factor TFAP2B is associated with insulin resistance and adiposity in healthy adolescents.Obesity (Silver Spring). 2009 Sep;17(9):1762-7. doi: 10.1038/oby.2009.83. Epub 2009 Mar 26.
381 MMP-2, MMP-9, and TIMP-4 and Response to Aspirin in Diabetic and Nondiabetic Patients with Stable Coronary Artery Disease: A Pilot Study.Biomed Res Int. 2017;2017:9352015. doi: 10.1155/2017/9352015. Epub 2017 Jul 10.
382 Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial.Circulation. 2018 Aug 21;138(8):770-781. doi: 10.1161/CIRCULATIONAHA.117.032318.
383 TRAF5 deficiency accelerates atherogenesis in mice by increasing inflammatory cell recruitment and foam cell formation.Circ Res. 2010 Sep 17;107(6):757-66. doi: 10.1161/CIRCRESAHA.110.219295. Epub 2010 Jul 22.
384 Infrequent TRIB3 coding variants and coronary artery disease in type 2 diabetes.Atherosclerosis. 2015 Sep;242(1):334-9. doi: 10.1016/j.atherosclerosis.2015.07.030. Epub 2015 Jul 17.
385 Increased serum levels of fetuin B in patients with coronary artery disease.Endocrine. 2017 Oct;58(1):97-105. doi: 10.1007/s12020-017-1387-1. Epub 2017 Aug 19.
386 RFX1 downregulation contributes to TLR4 overexpression in CD14(+) monocytes via epigenetic mechanisms in coronary artery disease.Clin Epigenetics. 2019 Mar 11;11(1):44. doi: 10.1186/s13148-019-0646-9.
387 Effect of genetic variant (rs11887534) in ABCG8 gene in coronary artery disease and response to atorvastatin therapy. Dis Markers. 2010;28(5):307-13.
388 ACP1 genetic polymorphism and coronary artery disease: an association study.Cardiology. 2009;113(4):236-42. doi: 10.1159/000203405. Epub 2009 Feb 25.
389 ADA*2 allele of the adenosine deaminase gene may protect against coronary artery disease.Cardiology. 2007;108(4):275-81. doi: 10.1159/000099096. Epub 2007 Feb 8.
390 A novel-1364A/C aquaporin 5 gene promoter polymorphism influences the responses to salt loading of the renin-angiotensin-aldosterone system and of blood pressure in young healthy men.Basic Res Cardiol. 2008 Nov;103(6):598-610. doi: 10.1007/s00395-008-0750-z. Epub 2008 Oct 10.
391 Detection of Left Ventricular Hypertrophy Using Bayesian Additive Regression Trees: The MESA.J Am Heart Assoc. 2019 Mar 5;8(5):e009959. doi: 10.1161/JAHA.118.009959.
392 Heterogeneity of high density lipoprotein particles.Circulation. 1993 Apr;87(4 Suppl):III22-7.
393 Association of the diabetes gene calpain-10 with subclinical atherosclerosis: the Mexican-American Coronary Artery Disease Study.Diabetes. 2005 Apr;54(4):1228-32. doi: 10.2337/diabetes.54.4.1228.
394 Hypercholesterolemia and hyper-alpha-lipoproteinemia in schoolchildren.Pediatrics. 1978 Oct;62(4):478-87.
395 CIRBP protects H9C2 cells against myocardial ischemia through inhibition of NF-B pathway.Braz J Med Biol Res. 2017 Mar 23;50(4):e5861. doi: 10.1590/1414-431X20175861.
396 Dectin-1 Contributes to Myocardial Ischemia/Reperfusion Injury by Regulating Macrophage Polarization and Neutrophil Infiltration.Circulation. 2019 Jan 29;139(5):663-678. doi: 10.1161/CIRCULATIONAHA.118.036044.
397 Post receptor determinants of acute platelet response to clopidogrel in patients with symptomatic myocardial ischemia.Vascul Pharmacol. 2015 Feb-Mar;65-66:17-22. doi: 10.1016/j.vph.2014.11.003. Epub 2014 Nov 20.
398 The Formin, DIAPH1, is a Key Modulator of Myocardial Ischemia/Reperfusion Injury.EBioMedicine. 2017 Dec;26:165-174. doi: 10.1016/j.ebiom.2017.11.012. Epub 2017 Nov 21.
399 Postprandial response to a fat tolerance test in young adults with a paternal history of premature coronary heart disease - the EARS II study (European Atherosclerosis Research Study).Eur J Clin Invest. 2000 Jul;30(7):578-85. doi: 10.1046/j.1365-2362.2000.00674.x.
400 Heat shock protein 70 protects cardiomyocytes through suppressing SUMOylation and nucleus translocation of phosphorylated eukaryotic elongation factor 2 during myocardial ischemia and reperfusion.Apoptosis. 2017 May;22(5):608-625. doi: 10.1007/s10495-017-1355-5.
401 Histopathologic signs for the inflammatory role of Chlamydia pneumoniae in the high-grade atherosclerotic coronary artery wall.Angiology. 2004 Sep-Oct;55(5):525-31. doi: 10.1177/000331970405500508.
402 AKT2 Blocks Nucleus Translocation of Apoptosis-Inducing Factor (AIF) and Endonuclease G (EndoG) While Promoting Caspase Activation during Cardiac Ischemia.Int J Mol Sci. 2017 Mar 6;18(3):565. doi: 10.3390/ijms18030565.
403 Association Between Stress Testing-Induced Myocardial Ischemia and Clinical Events in Patients With Multivessel Coronary Artery Disease.JAMA Intern Med. 2019 Oct 1;179(10):1345-1351. doi: 10.1001/jamainternmed.2019.2227.
404 Pathogenesis of cardiac ischemia reperfusion injury is associated with CK2-disturbed mitochondrial homeostasis via suppression of FUNDC1-related mitophagy.Cell Death Differ. 2018 Jun;25(6):1080-1093. doi: 10.1038/s41418-018-0086-7. Epub 2018 Mar 14.
405 Downregulation of miR-151-5p contributes to increased susceptibility to arrhythmogenesis during myocardial infarction with estrogen deprivation.PLoS One. 2013 Sep 9;8(9):e72985. doi: 10.1371/journal.pone.0072985. eCollection 2013.
406 A preliminary study of the relationship between promoter methylation of the ABCG1, GALNT2 and HMGCR genes and coronary heart disease. PLoS One. 2014 Aug 1;9(8):e102265.
407 Effect of Geranylgeranyl Pyrophosphate Synthase on Hypoxia/Reoxygenation-Induced Injury in Heart-Derived H9c2 Cells.Int Heart J. 2018 Jul 31;59(4):821-828. doi: 10.1536/ihj.17-218. Epub 2018 May 23.
408 A point mutation in ABC1 gene in a patient with severe premature coronary heart disease and mild clinical phenotype of Tangier disease.Atherosclerosis. 2001 Feb 15;154(3):599-605. doi: 10.1016/s0021-9150(00)00587-6.
409 circDLPAG4/HECTD1 mediates ischaemia/reperfusion injury in endothelial cells via ER stress.RNA Biol. 2020 Feb;17(2):240-253. doi: 10.1080/15476286.2019.1676114. Epub 2019 Oct 13.
410 The INSIG1 gene, not the INSIG2 gene, associated with coronary heart disease: tagSNPs and haplotype-based association study. The Beijing Atherosclerosis Study.Thromb Haemost. 2008 Nov;100(5):886-92.
411 Over-expression of JAZF1 promotes cardiac microvascular endothelial cell proliferation and angiogenesis via activation of the Akt signaling pathway in rats with myocardial ischemia-reperfusion.Cell Cycle. 2019 Jul;18(14):1619-1634. doi: 10.1080/15384101.2019.1629774. Epub 2019 Jun 18.
412 TIEG1 deficiency confers enhanced myocardial protection in the infarcted heart by mediating the Pten/Akt signalling pathway.Int J Mol Med. 2017 Mar;39(3):569-578. doi: 10.3892/ijmm.2017.2889. Epub 2017 Feb 13.
413 Association between coronary heart disease and the C3F-gene in essential hypertension.Circulation. 1978 Oct;58(4):622-5. doi: 10.1161/01.cir.58.4.622.
414 Technical note: EnVision?FLEX improves the detectability of depletions of myoglobin and troponin T in forensic cases of myocardial ischemia/infarction.Int J Legal Med. 2017 Nov;131(6):1643-1646. doi: 10.1007/s00414-017-1575-9. Epub 2017 Mar 23.
415 Baicalin Depresses the Sympathoexcitatory Reflex Induced by Myocardial Ischemia via the Dorsal Root Ganglia.Front Physiol. 2018 Jul 17;9:928. doi: 10.3389/fphys.2018.00928. eCollection 2018.
416 MCU Up-regulation contributes to myocardial ischemia-reperfusion Injury through calpain/OPA-1-mediated mitochondrial fusion/mitophagy Inhibition.J Cell Mol Med. 2019 Nov;23(11):7830-7843. doi: 10.1111/jcmm.14662. Epub 2019 Sep 9.
417 The role of RIP3 in cardiomyocyte necrosis induced by mitochondrial damage of myocardial ischemia-reperfusion.Acta Biochim Biophys Sin (Shanghai). 2018 Nov 1;50(11):1131-1140. doi: 10.1093/abbs/gmy108.
418 Melanocortins as potential therapeutic agents in severe hypoxic conditions.Front Neuroendocrinol. 2012 Apr;33(2):179-93. doi: 10.1016/j.yfrne.2012.04.001. Epub 2012 Apr 17.
419 Association of PARL rs3732581 genetic variant with insulin levels, metabolic syndrome and coronary artery disease.Hum Genet. 2008 Oct;124(3):263-70. doi: 10.1007/s00439-008-0552-2. Epub 2008 Aug 30.
420 Tumor necrosis factor-alpha upregulated PHLPP1 through activating nuclear factor-kappa B during myocardial ischemia/reperfusion.Life Sci. 2018 Aug 15;207:355-363. doi: 10.1016/j.lfs.2018.06.023. Epub 2018 Jun 22.
421 PIAS1 protects against myocardial ischemia-reperfusion injury by stimulating PPAR SUMOylation.BMC Cell Biol. 2018 Nov 12;19(1):24. doi: 10.1186/s12860-018-0176-x.
422 Perilipin 5 is protective in the ischemic heart.Int J Cardiol. 2016 Sep 15;219:446-54. doi: 10.1016/j.ijcard.2016.06.037. Epub 2016 Jun 16.
423 Fifteen new risk loci for coronary artery disease highlight arterial-wall-specific mechanisms.Nat Genet. 2017 Jul;49(7):1113-1119. doi: 10.1038/ng.3874. Epub 2017 May 22.
424 Adipokine Chemerin Stimulates Progression of Atherosclerosis in ApoE(-/-) Mice.Biomed Res Int. 2019 Oct 31;2019:7157865. doi: 10.1155/2019/7157865. eCollection 2019.
425 Calcineurin and its regulator, RCAN1, confer time-of-day changes in susceptibility of the heart to ischemia/reperfusion.J Mol Cell Cardiol. 2014 Sep;74:103-11. doi: 10.1016/j.yjmcc.2014.05.004. Epub 2014 May 15.
426 PTPIP51 regulates mouse cardiac ischemia/reperfusion through mediating the mitochondria-SR junction.Sci Rep. 2017 Mar 27;7:45379. doi: 10.1038/srep45379.
427 Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a -786T-->C mutation associated with coronary spastic angina.Hum Mol Genet. 2000 Nov 1;9(18):2629-37. doi: 10.1093/hmg/9.18.2629.
428 Variation in the selenoprotein S gene locus is associated with coronary heart disease and ischemic stroke in two independent Finnish cohorts.Hum Genet. 2007 Nov;122(3-4):355-65. doi: 10.1007/s00439-007-0402-7. Epub 2007 Jul 20.
429 The desumoylating enzyme sentrin-specific protease 3 contributes to myocardial ischemia reperfusion injury.J Genet Genomics. 2018 Mar 20;45(3):125-135. doi: 10.1016/j.jgg.2017.12.002. Epub 2017 Dec 29.
430 The TAB1-p38 complex aggravates myocardial injury and can be targeted by small molecules.JCI Insight. 2018 Aug 23;3(16):e121144. doi: 10.1172/jci.insight.121144. eCollection 2018 Aug 23.
431 Genetic variants of Y chromosome are associated with a protective lipid profile in black men.Arterioscler Thromb Vasc Biol. 2008 Aug;28(8):1569-74. doi: 10.1161/ATVBAHA.108.168641. Epub 2008 May 29.
432 TRAF1 Exacerbates Myocardial Ischemia Reperfusion Injury via ASK1-JNK/p38 Signaling.J Am Heart Assoc. 2019 Nov 5;8(21):e012575. doi: 10.1161/JAHA.119.012575. Epub 2019 Oct 25.
433 Role of Toll-like receptors and interferon regulatory factors in different experimental heart failure models of diverse etiology: IRF7 as novel cardiovascular stress-inducible factor.PLoS One. 2018 Mar 14;13(3):e0193844. doi: 10.1371/journal.pone.0193844. eCollection 2018.
434 Determinants and Long-Term Outcomes of Percutaneous Coronary Interventions vs. Surgery for Multivessel Disease According to Clinical Presentation.Circ J. 2018 Mar 23;82(4):1092-1100. doi: 10.1253/circj.CJ-17-1173. Epub 2018 Feb 9.
435 ACAT2 is a target for treatment of coronary heart disease associated with hypercholesterolemia.Arterioscler Thromb Vasc Biol. 2005 Jun;25(6):1112-8. doi: 10.1161/01.ATV.0000166548.65753.1e. Epub 2005 Apr 14.
436 ACTA2 mutation and postpartum hemorrhage: a case report.BMC Med Genet. 2017 Dec 4;18(1):143. doi: 10.1186/s12881-017-0505-5.
437 Association of alpha-adducin Gly460Trp polymorphism with coronary artery disease in a Korean population.J Hypertens. 2007 Dec;25(12):2413-20. doi: 10.1097/HJH.0b013e3282efedb5.
438 Genetic variation in the adiponectin receptor 2 (ADIPOR2) gene is associated with coronary artery disease and increased ADIPOR2 expression in peripheral monocytes.Cardiovasc Diabetol. 2010 Feb 23;9:10. doi: 10.1186/1475-2840-9-10.
439 Identification of a molecular signaling gene-gene regulatory network between GWAS susceptibility genes ADTRP and MIA3/TANGO1 for coronary artery disease.Biochim Biophys Acta Mol Basis Dis. 2017 Jun;1863(6):1640-1653. doi: 10.1016/j.bbadis.2017.03.010. Epub 2017 Mar 21.
440 Correlation between the GP78 Gene Polymorphism and Coronary Atherosclerotic Heart Disease.Hellenic J Cardiol. 2018 Jan-Feb;59(1):8-13. doi: 10.1016/j.hjc.2017.02.001. Epub 2017 Feb 15.
441 Association of C34T AMPD1 gene polymorphism with features of metabolic syndrome in patients with coronary artery disease or heart failure.Scand J Clin Lab Invest. 2009;69(1):102-12. doi: 10.1080/00365510802430964.
442 Associations between circulating full-length angiopoietin-like protein 8 levels and severity of coronary artery disease in Chinese non-diabetic patients: a case-control study.Cardiovasc Diabetol. 2018 Jun 25;17(1):92. doi: 10.1186/s12933-018-0736-6.
443 Associations of genetics, behaviors, and life course circumstances with a novel aging and healthspan measure: Evidence from the Health and Retirement Study.PLoS Med. 2019 Jun 18;16(6):e1002827. doi: 10.1371/journal.pmed.1002827. eCollection 2019 Jun.
444 Correlation analysis between ApoM gene-promoter polymorphisms and coronary heart disease.Cardiovasc J Afr. 2016 Jul/Aug;27(4):228-237. doi: 10.5830/CVJA-2016-001.
445 The apoptosis inhibitor ARC undergoes ubiquitin-proteasomal-mediated degradation in response to death stimuli: identification of a degradation-resistant mutant.J Biol Chem. 2007 Feb 23;282(8):5522-8. doi: 10.1074/jbc.M609186200. Epub 2006 Dec 1.
446 ARL15 overexpression attenuates high glucose-induced impairment of insulin signaling and oxidative stress in human umbilical vein endothelial cells.Life Sci. 2019 Mar 1;220:127-135. doi: 10.1016/j.lfs.2019.01.030. Epub 2019 Jan 22.
447 Outcome after revascularisation of acute myocardial infarction with cardiogenic shock on extracorporeal life support.EuroIntervention. 2018 Apr 6;13(18):e2160-e2168. doi: 10.4244/EIJ-D-17-01014.
448 What determines do-not-resuscitate status in critically ill HIV-infected patients admitted to ICU?.J Crit Care. 2019 Oct;53:207-211. doi: 10.1016/j.jcrc.2019.06.010. Epub 2019 Jun 19.
449 The Value of the SYNTAX Score II in Predicting Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation.Rev Esp Cardiol (Engl Ed). 2018 Aug;71(8):628-637. doi: 10.1016/j.rec.2017.10.014. Epub 2017 Nov 28.
450 Association of C1q/TNF-related protein-1 (CTRP1) serum levels with coronary artery disease.J Int Med Res. 2019 Jun;47(6):2571-2579. doi: 10.1177/0300060519847372. Epub 2019 May 13.
451 Decreased serum levels of CTRP12/adipolin in patients with coronary artery disease in relation to inflammatory cytokines and insulin resistance.Cytokine. 2019 Jan;113:326-331. doi: 10.1016/j.cyto.2018.09.019. Epub 2018 Oct 15.
452 Autoantibodies Against (1)-Adrenoceptor Exaggerated Ventricular Remodeling by Inhibiting CTRP9 Expression.J Am Heart Assoc. 2019 Feb 19;8(4):e010475. doi: 10.1161/JAHA.118.010475.
453 Association of C5L2 genetic polymorphisms with coronary artery disease in a Han population in Xinjiang, China.Oncotarget. 2017 Jan 31;8(5):8590-8596. doi: 10.18632/oncotarget.14353.
454 Camk2n1 Is a Negative Regulator of Blood Pressure, Left Ventricular Mass, Insulin Sensitivity, and Promotes Adiposity.Hypertension. 2019 Sep;74(3):687-696. doi: 10.1161/HYPERTENSIONAHA.118.12409. Epub 2019 Jul 22.
455 Aberrant histone modifications of global histone and MCP-1 promoter in CD14(+) monocytes from patients with coronary artery disease.Pharmazie. 2018 Apr 2;73(4):202-206. doi: 10.1691/ph.2018.7342.
456 Common Variants in TRDN and CALM1 Are Associated with Risk of Sudden Cardiac Death in Chronic Heart Failure Patients in Chinese Han Population.PLoS One. 2015 Jul 21;10(7):e0132459. doi: 10.1371/journal.pone.0132459. eCollection 2015.
457 Elevated methylation of cyclin dependent kinase inhibitor 2B contributes to the risk of coronary heart disease in women.Exp Ther Med. 2019 Jan;17(1):205-213. doi: 10.3892/etm.2018.6920. Epub 2018 Nov 2.
458 CELSR2-PSRC1-SORT1 gene expression and association with coronary artery disease and plasma lipid levels in an Asian Indian cohort.J Cardiol. 2014 Nov;64(5):339-46. doi: 10.1016/j.jjcc.2014.02.012. Epub 2014 Mar 24.
459 Plasma soluble C-type lectin-like receptor-2 is associated with the risk of coronary artery disease.Front Med. 2020 Feb;14(1):81-90. doi: 10.1007/s11684-019-0692-x. Epub 2019 Jul 6.
460 Association of COL4A1 (rs605143, rs565470) and CD14 (rs2569190) genes polymorphism with coronary artery disease.Mol Cell Biochem. 2018 Aug;445(1-2):117-122. doi: 10.1007/s11010-017-3257-9. Epub 2018 Jan 3.
461 Combining high-sensitivity cardiac troponin and B-type natriuretic peptide in the detection of inducible myocardial ischemia.Clin Biochem. 2018 Feb;52:33-40. doi: 10.1016/j.clinbiochem.2017.10.014. Epub 2017 Nov 8.
462 Polymorphism of bovine beta-casein and its potential effect on human health.J Appl Genet. 2007;48(3):189-98. doi: 10.1007/BF03195213.
463 Genetic overlap between birthweight and adult cardiometabolic diseases has implications for genomic medicine.Sci Rep. 2019 Mar 11;9(1):4076. doi: 10.1038/s41598-019-40834-w.
464 Association of the single nucleotide polymorphism in chromosome 9p21 and chromosome 9q33 with coronary artery disease in Chinese population.BMC Cardiovasc Disord. 2017 Sep 30;17(1):255. doi: 10.1186/s12872-017-0685-0.
465 Mortality implications of lower DBP with lower achieved systolic pressures in coronary artery disease: long-term mortality results from the INternational VErapamil-trandolapril STudy US cohort.J Hypertens. 2018 Feb;36(2):419-427. doi: 10.1097/HJH.0000000000001559.
466 A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with myocardial infarction in type 2 diabetic patients.Cardiovasc Diabetol. 2019 Aug 13;18(1):102. doi: 10.1186/s12933-019-0906-1.
467 Roles of NADPH oxidase and mitochondria in flow-induced vasodilation of human adipose arterioles: ROS-induced ROS release in coronary artery disease.Microcirculation. 2017 Aug;24(6):10.1111/micc.12380. doi: 10.1111/micc.12380.
468 DOCK7-ANGPTL3 SNPs and their haplotypes with serum lipid levels and the risk of coronary artery disease and ischemic stroke.Lipids Health Dis. 2018 Feb 17;17(1):30. doi: 10.1186/s12944-018-0677-9.
469 Del-1 gene transfer induces cerebral angiogenesis in mice.Brain Res. 2008 Jul 11;1219:1-7. doi: 10.1016/j.brainres.2008.05.003. Epub 2008 May 10.
470 Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury.Circ Res. 1998 Jul 13;83(1):85-94. doi: 10.1161/01.res.83.1.85.
471 Higher serum level of CTRP15 in patients with coronary artery disease is associated with disease severity, body mass index and insulin resistance.Arch Physiol Biochem. 2022 Feb;128(1):276-280. doi: 10.1080/13813455.2019.1675713. Epub 2019 Oct 12.
472 Circulating ESM-1 levels are correlated with the presence of coronary artery disease in patients with obstructive sleep apnea.Respir Res. 2019 Aug 20;20(1):188. doi: 10.1186/s12931-019-1143-6.
473 A genome-wide trans-ethnic interaction study links the PIGR-FCAMR locus to coronary atherosclerosis via interactions between genetic variants and residential exposure to traffic.PLoS One. 2017 Mar 29;12(3):e0173880. doi: 10.1371/journal.pone.0173880. eCollection 2017.
474 Genetic polymorphisms in platelet-related proteins and coronary artery disease: investigation of candidate genes, including N-acetylgalactosaminyltransferase 4 (GALNT4) and sulphotransferase 1A1/2 (SULT1A1/2).J Thromb Thrombolysis. 2009 Feb;27(2):175-84. doi: 10.1007/s11239-008-0196-z. Epub 2008 Feb 8.
475 Polymorphisms within vitamin D binding protein gene within a Preeclamptic South African population.Hypertens Pregnancy. 2019 Nov;38(4):260-267. doi: 10.1080/10641955.2019.1667383. Epub 2019 Sep 27.
476 Association of common gene variants in glucokinase regulatory protein with cardiorenal disease: A systematic review and meta-analysis.PLoS One. 2018 Oct 23;13(10):e0206174. doi: 10.1371/journal.pone.0206174. eCollection 2018.
477 Glia maturation factor-gamma is preferentially expressed in microvascular endothelial and inflammatory cells and modulates actin cytoskeleton reorganization.Circ Res. 2006 Aug 18;99(4):424-33. doi: 10.1161/01.RES.0000237662.23539.0b. Epub 2006 Jul 27.
478 GNB3 gene 825 TT variant predicts hard coronary events in the population-based Heinz Nixdorf Recall study.Atherosclerosis. 2014 Dec;237(2):437-42. doi: 10.1016/j.atherosclerosis.2014.08.025. Epub 2014 Aug 28.
479 The role of plasma lipoprotein lipase, hepatic lipase and GPIHBP1 in the metabolism of remnant lipoproteins and small dense LDL in patients with coronary artery disease.Clin Chim Acta. 2018 Jan;476:146-153. doi: 10.1016/j.cca.2017.11.021. Epub 2017 Nov 22.
480 Enzymatic Activity Is Not Required for Phospholipase D Mediated TNF- Regulation and Myocardial Healing.Front Physiol. 2018 Nov 29;9:1698. doi: 10.3389/fphys.2018.01698. eCollection 2018.
481 HHIPL1, a Gene at the 14q32 Coronary Artery Disease Locus, Positively Regulates Hedgehog Signaling and Promotes Atherosclerosis.Circulation. 2019 Aug 6;140(6):500-513. doi: 10.1161/CIRCULATIONAHA.119.041059. Epub 2019 Jun 5.
482 Plasma heat shock protein 60 and cardiovascular disease risk: the role of psychosocial, genetic, and biological factors.Cell Stress Chaperones. 2007 Winter;12(4):384-92. doi: 10.1379/csc-300.1.
483 Myocardial immediate early gene activation after cardiopulmonary bypass with cardiac ischemia-reperfusion.Ann Thorac Surg. 2002 Jan;73(1):156-62. doi: 10.1016/s0003-4975(01)03303-3.
484 Free IGF-1, Intact IGFBP-4, and PicoPAPP-A are Altered in Acute Myocardial Infarction Compared to Stable Coronary Artery Disease and Healthy Controls.Horm Metab Res. 2019 Feb;51(2):112-119. doi: 10.1055/a-0794-6163. Epub 2018 Nov 29.
485 Proteomic Biomarkers for Incident Aortic Stenosis Requiring Valvular Replacement.Circulation. 2018 Aug 7;138(6):590-599. doi: 10.1161/CIRCULATIONAHA.117.030414.
486 IL-18 binding protein-expressing mesenchymal stem cells improve myocardial protection after ischemia or infarction.Proc Natl Acad Sci U S A. 2009 Oct 13;106(41):17499-504. doi: 10.1073/pnas.0908924106. Epub 2009 Sep 25.
487 Prognostic Significance of Interleukin-34 (IL-34) in Patients With Chronic Heart Failure With or Without Renal Insufficiency.J Am Heart Assoc. 2017 Apr 1;6(4):e004911. doi: 10.1161/JAHA.116.004911.
488 Association of Interleukin 6 Receptor Variant With Cardiovascular Disease Effects of Interleukin 6 Receptor Blocking Therapy: A Phenome-Wide Association Study.JAMA Cardiol. 2018 Sep 1;3(9):849-857. doi: 10.1001/jamacardio.2018.2287.
489 Gene therapy with inducible nitric oxide synthase protects against myocardial infarction via a cyclooxygenase-2-dependent mechanism.Circ Res. 2003 Apr 18;92(7):741-8. doi: 10.1161/01.RES.0000065441.72685.29.
490 Evaluation of platelet reactivity during combined antiplatelet therapy in patients with stable coronary artery disease in relation to diabetes type 2 and the GPIIB/IIIA receptor gene polymorphism.J Physiol Pharmacol. 2019 Apr;70(2). doi: 10.26402/jpp.2019.2.01. Epub 2019 Jul 22.
491 The novel coronary artery disease risk gene JCAD/KIAA1462 promotes endothelial dysfunction and atherosclerosis.Eur Heart J. 2019 Aug 1;40(29):2398-2408. doi: 10.1093/eurheartj/ehz303.
492 Impaired HDL2-mediated cholesterol efflux is associated with metabolic syndrome in families with early onset coronary heart disease and low HDL-cholesterol level.PLoS One. 2017 Feb 16;12(2):e0171993. doi: 10.1371/journal.pone.0171993. eCollection 2017.
493 KALRN Rare and Common Variants and Susceptibility to Ischemic Stroke in Chinese Han Population.Neuromolecular Med. 2015 Sep;17(3):241-50. doi: 10.1007/s12017-015-8352-z. Epub 2015 Apr 28.
494 Mouse model of Prinzmetal angina by disruption of the inward rectifier Kir6.1.Nat Med. 2002 May;8(5):466-72. doi: 10.1038/nm0502-466.
495 Survival bias and drug interaction can attenuate cross-sectional case-control comparisons of genes with health outcomes. An example of the kinesin-like protein 6 (KIF6) Trp719Arg polymorphism and coronary heart disease.BMC Med Genet. 2011 Mar 24;12:42. doi: 10.1186/1471-2350-12-42.
496 Association between KIF6 rs20455 polymorphism and the risk of coronary heart disease (CHD): a pooled analysis of 50 individual studies including 40,059 cases and 64,032 controls.Lipids Health Dis. 2018 Jan 5;17(1):4. doi: 10.1186/s12944-017-0651-y.
497 Klotho, fibroblast growth factor-23, and the renin-angiotensin system - an analysis from the PEACE trial.Eur J Heart Fail. 2019 Apr;21(4):462-470. doi: 10.1002/ejhf.1424. Epub 2019 Feb 18.
498 Krppel-like factor 14, a coronary artery disease associated transcription factor, inhibits endothelial inflammation via NF-B signaling pathway.Atherosclerosis. 2018 Nov;278:39-48. doi: 10.1016/j.atherosclerosis.2018.09.018. Epub 2018 Sep 15.
499 Significant role and mechanism of microRNA-143-3p/KLLN axis in the development of coronary heart disease.Am J Transl Res. 2019 Jun 15;11(6):3610-3619. eCollection 2019.
500 microRNA-107 protects against inflammation and endoplasmic reticulum stress of vascular endothelial cells via KRT1-dependent Notch signaling pathway in a mouse model of coronary atherosclerosis.J Cell Physiol. 2019 Jul;234(7):12029-12041. doi: 10.1002/jcp.27864. Epub 2018 Dec 12.
501 Multi-organ expression profiling uncovers a gene module in coronary artery disease involving transendothelial migration of leukocytes and LIM domain binding 2: the Stockholm Atherosclerosis Gene Expression (STAGE) study.PLoS Genet. 2009 Dec;5(12):e1000754. doi: 10.1371/journal.pgen.1000754. Epub 2009 Dec 4.
502 Smaller low-density lipoprotein size as a possible risk factor for the prevalence of coronary artery diseases in haemodialysis patients: associations of cholesteryl ester transfer protein and the hepatic lipase gene polymorphism with low-density lipoprotein size.Nephrology (Carlton). 2011 Aug;16(6):558-66. doi: 10.1111/j.1440-1797.2011.01454.x.
503 Functional regulatory mechanism of smooth muscle cell-restricted LMOD1 coronary artery disease locus.PLoS Genet. 2018 Nov 16;14(11):e1007755. doi: 10.1371/journal.pgen.1007755. eCollection 2018 Nov.
504 Expression of mRNA isoforms of latent transforming growth factor- binding protein-1 in coronary atherosclerosis and human tissues.Biochem Genet. 2011 Apr;49(3-4):213-25. doi: 10.1007/s10528-010-9400-x. Epub 2010 Dec 15.
505 Dissecting the association of autophagy-related genes with cardiovascular diseases and intermediate vascular traits: A population-based approach.PLoS One. 2019 Mar 25;14(3):e0214137. doi: 10.1371/journal.pone.0214137. eCollection 2019.
506 Phenotypic Refinement of Heart Failure in a National Biobank Facilitates Genetic Discovery.Circulation. 2019 Jan 22;139(4):489-501. doi: 10.1161/CIRCULATIONAHA.118.035774. Epub 2018 Nov 11.
507 Association of +45(T/G) and +276(G/T) polymorphisms in the adiponectin gene with coronary artery disease in a population of Iranian patients with type 2 diabetes.Mol Biol Rep. 2012 Apr;39(4):3791-7. doi: 10.1007/s11033-011-1156-9. Epub 2011 Jul 10.
508 Lower serum levels of Meteorin-like/Subfatin in patients with coronary artery disease and type 2 diabetes mellitus are negatively associated with insulin resistance and inflammatory cytokines.PLoS One. 2018 Sep 13;13(9):e0204180. doi: 10.1371/journal.pone.0204180. eCollection 2018.
509 C771G (His241Gln) polymorphism of MLXIPL gene, TG levels and coronary artery disease: a case control study.Anatol J Cardiol. 2015 Jan;15(1):8-12. doi: 10.5152/akd.2014.5135. Epub 2014 Feb 10.
510 Interleukin-18, matrix metalloproteinase-22 and -29 are independent risk factors of human coronary heart disease.J Zhejiang Univ Sci B. 2017 Aug.;18(8):685-695. doi: 10.1631/jzus.B1700073.
511 Common Variant in Glycoprotein Ia Increases Long-Term Adverse Events Risk After Coronary Artery Bypass Graft Surgery.J Am Heart Assoc. 2016 Nov 23;5(12):e004496. doi: 10.1161/JAHA.116.004496.
512 Impact of Mon2 monocyte-platelet aggregates on human coronary artery disease.Eur J Clin Invest. 2018 May;48(5):e12911. doi: 10.1111/eci.12911. Epub 2018 Mar 7.
513 Contemporary Discrepancies of Stenosis Assessment by Computed Tomography and Invasive Coronary Angiography.Circ Cardiovasc Imaging. 2019 Feb;12(2):e007720. doi: 10.1161/CIRCIMAGING.118.007720.
514 MKL1-184C>T gene polymorphism is associated with coronary artery disease in the Chinese Han population.Genet Mol Res. 2014 Jan 28;13(1):590-7. doi: 10.4238/2014.January.28.4.
515 Genetic etiology of coronary artery disease considering NOS 3 gene variant rs1799983.Vascular. 2015 Jun;23(3):270-6. doi: 10.1177/1708538114544783. Epub 2014 Jul 23.
516 Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1): A potential biomarker for coronary artery disease in patients with obstructive sleep apnea.PLoS One. 2018 Mar 29;13(3):e0195015. doi: 10.1371/journal.pone.0195015. eCollection 2018.
517 Gene variants in the NF-KB pathway (NFKB1, NFKBIA, NFKBIZ) and risk for early-onset coronary artery disease.Immunol Lett. 2019 Apr;208:39-43. doi: 10.1016/j.imlet.2019.02.007. Epub 2019 Mar 19.
518 Assessment of nociceptin/orphanin FQ and micro-opioid receptor mRNA in the human right atrium.Br J Anaesth. 2010 Jun;104(6):698-704. doi: 10.1093/bja/aeq089. Epub 2010 Apr 21.
519 The inflammasome NLRP12 is associated with both depression and coronary artery disease in Vietnam veterans.Psychiatry Res. 2018 Dec;270:775-779. doi: 10.1016/j.psychres.2018.10.051. Epub 2018 Oct 27.
520 Expression and vasoconstrictor function of anorexigenic peptides neuromedin U-25 and S in the human cardiovascular system.Cardiovasc Res. 2009 Feb 1;81(2):353-61. doi: 10.1093/cvr/cvn302. Epub 2008 Nov 5.
521 A common NOS1AP genetic polymorphism, rs12567209 G>A, is associated with sudden cardiac death in patients with chronic heart failure in the Chinese Han population.J Card Fail. 2014 Apr;20(4):244-51. doi: 10.1016/j.cardfail.2014.01.006. Epub 2014 Jan 10.
522 Establishing the precise evolutionary history of a gene improves prediction of disease-causing missense mutations.Genet Med. 2016 Oct;18(10):1029-36. doi: 10.1038/gim.2015.208. Epub 2016 Feb 18.
523 Associations between plasma nesfatin-1 levels and the presence and severity of coronary artery disease.Heart Vessels. 2019 Jun;34(6):965-970. doi: 10.1007/s00380-018-01328-3. Epub 2019 Jan 1.
524 Breast arterial calcification on mammography and risk of coronary artery disease: a SCOT-HEART sub-study.Clin Radiol. 2019 Jun;74(6):421-428. doi: 10.1016/j.crad.2019.01.014. Epub 2019 Feb 22.
525 Peptidylarginine Deiminase 2 Knockout Improves Survival in hemorrhagic shock.Shock. 2020 Oct;54(4):458-463. doi: 10.1097/SHK.0000000000001489.
526 Treatment with triple combination of atorvastatin, perindopril, and amlodipine in patients with stable coronary artery disease: A subgroup analysis from the PAPA-CAD study.J Int Med Res. 2018 May;46(5):1902-1909. doi: 10.1177/0300060518760158. Epub 2018 Mar 20.
527 PDCD4 expression in coronary atherosclerosis rat models and its mechanism.Exp Ther Med. 2019 Apr;17(4):3150-3154. doi: 10.3892/etm.2019.7296. Epub 2019 Feb 22.
528 PEAR1 is not a major susceptibility gene for cardiovascular disease in a Flemish population.BMC Med Genet. 2017 Apr 27;18(1):45. doi: 10.1186/s12881-017-0411-x.
529 PHACTR1 gene polymorphism with the risk of coronary artery disease in Chinese Han population.Postgrad Med J. 2019 Feb;95(1120):67-71. doi: 10.1136/postgradmedj-2018-136298. Epub 2019 Feb 18.
530 Low expression of PIK3C2A gene: A potential biomarker to predict the risk of acute myocardial infarction.Medicine (Baltimore). 2019 Apr;98(14):e15061. doi: 10.1097/MD.0000000000015061.
531 Increased plasma levels of CATS mRNA but not CATB mRNA in patients with coronary atherosclerosis.Clin Biochem. 2010 Dec;43(18):1427-30. doi: 10.1016/j.clinbiochem.2010.09.017. Epub 2010 Sep 27.
532 Alterations of protein expression of phospholamban, ZASP and plakoglobin in human atria in subgroups of seniors.Sci Rep. 2019 Apr 4;9(1):5610. doi: 10.1038/s41598-019-42141-w.
533 Novel genetic approach to investigate the role of plasma secretory phospholipase A2 (sPLA2)-V isoenzyme in coronary heart disease: modified Mendelian randomization analysis using PLA2G5 expression levels.Circ Cardiovasc Genet. 2014 Apr;7(2):144-50. doi: 10.1161/CIRCGENETICS.113.000271. Epub 2014 Feb 21.
534 Translational studies of lipoprotein-associated phospholipase A?in inflammation and atherosclerosis.J Am Coll Cardiol. 2012 Feb 21;59(8):764-72. doi: 10.1016/j.jacc.2011.11.019.
535 Exploring calcium ion-dependent effect on the intermolecular interaction between human secreted phospholipase A2 and its peptide inhibitors in coronary artery disease.J Mol Graph Model. 2019 Dec;93:107449. doi: 10.1016/j.jmgm.2019.107449. Epub 2019 Sep 7.
536 Coronary Artery Disease Risk-Associated Plpp3 Gene and Its Product Lipid Phosphate Phosphatase 3 Regulate Experimental Atherosclerosis.Arterioscler Thromb Vasc Biol. 2019 Nov;39(11):2261-2272. doi: 10.1161/ATVBAHA.119.313056. Epub 2019 Sep 19.
537 Mechanisms of Myocardial Infarction inPatients With Nonobstructive Coronary Artery Disease: Results From the Optical Coherence Tomography Study.JACC Cardiovasc Imaging. 2019 Nov;12(11 Pt 1):2210-2221. doi: 10.1016/j.jcmg.2018.08.022. Epub 2018 Oct 17.
538 In vitro and in vivo metabolite identification of a novel benzimidazole compound ZLN005 by liquid chromatography/tandem mass spectrometry.Rapid Commun Mass Spectrom. 2018 Mar 30;32(6):480-488. doi: 10.1002/rcm.8060.
539 The utility of inflammation and platelet biomarkers in patients with acute coronary syndromes.Saudi J Biol Sci. 2018 Nov;25(7):1263-1271. doi: 10.1016/j.sjbs.2016.10.015. Epub 2016 Oct 24.
540 High Serum Cyclophilin C levels as a risk factor marker for Coronary Artery Disease.Sci Rep. 2019 Jul 22;9(1):10576. doi: 10.1038/s41598-019-46988-x.
541 Potentially critical roles of TNPO1, RAP1B, ZDHHC17, and PPM1B in the progression of coronary atherosclerosis through microarray data analysis.J Cell Biochem. 2019 Mar;120(3):4301-4311. doi: 10.1002/jcb.27715. Epub 2018 Sep 30.
542 Identification of the growth arrest and DNA damage protein GADD34 in the normal human heart and demonstration of alterations in expression following myocardial ischaemia.Int J Cardiol. 2006 Feb 8;107(1):126-9. doi: 10.1016/j.ijcard.2005.01.051.
543 Association between functional variant of inflammatory system gene (PSMA6) and end-stage kidney disease.Int Urol Nephrol. 2016 Dec;48(12):2083-2087. doi: 10.1007/s11255-016-1420-y. Epub 2016 Sep 26.
544 PSRC1 overexpression attenuates atherosclerosis progression in apoE(-/-) mice by modulating cholesterol transportation and inflammation.J Mol Cell Cardiol. 2018 Mar;116:69-80. doi: 10.1016/j.yjmcc.2018.01.013. Epub 2018 Feb 3.
545 Association between triglyceride-rich lipoprotein remnant receptor polymorphisms and lipid traits.Clin Biochem. 2000 Aug;33(6):441-7. doi: 10.1016/s0009-9120(00)00139-9.
546 Pentraxin-3 in coronary artery disease: A meta-analysis.Cytokine. 2019 Jul;119:197-201. doi: 10.1016/j.cyto.2019.03.017. Epub 2019 Apr 4.
547 Targeted deletion of nuclear factor kappaB p50 enhances cardiac remodeling and dysfunction following myocardial infarction.Circ Res. 2009 Mar 13;104(5):699-706. doi: 10.1161/CIRCRESAHA.108.189746. Epub 2009 Jan 24.
548 Resistin promotes cardiac homing of mesenchymal stem cells and functional recovery after myocardial ischemia-reperfusion via the ERK1/2-MMP-9 pathway.Am J Physiol Heart Circ Physiol. 2019 Jan 1;316(1):H233-H244. doi: 10.1152/ajpheart.00457.2018. Epub 2018 Nov 9.
549 Circulating Relaxin-1 Level Is a Surrogate Marker of Myocardial Fibrosis in HFrEF.Front Physiol. 2019 Jun 4;10:690. doi: 10.3389/fphys.2019.00690. eCollection 2019.
550 Chronic lower-dose relaxin administration protects from arrhythmia in experimental myocardial infarction due to anti-inflammatory and anti-fibrotic properties.Int J Cardiol. 2018 Jan 1;250:21-28. doi: 10.1016/j.ijcard.2017.09.017.
551 Investigation of Renalase gene rs2576178 polymorphism in patients with coronary artery disease.Biosci Rep. 2018 Sep 13;38(5):BSR20180839. doi: 10.1042/BSR20180839. Print 2018 Oct 31.
552 RYR3 gene polymorphisms and cardiovascular disease outcomes in the context of antihypertensive treatment.Pharmacogenomics J. 2013 Aug;13(4):330-4. doi: 10.1038/tpj.2012.22. Epub 2012 Jun 5.
553 Secretoneurin suppresses cardiac hypertrophy through suppression of oxidant stress.Eur J Pharmacol. 2018 Mar 5;822:13-24. doi: 10.1016/j.ejphar.2018.01.008. Epub 2018 Jan 11.
554 Multivariate Genome-wide Association Analysis of a Cytokine Network Reveals Variants with Widespread Immune, Haematological, and Cardiometabolic Pleiotropy.Am J Hum Genet. 2019 Dec 5;105(6):1076-1090. doi: 10.1016/j.ajhg.2019.10.001. Epub 2019 Oct 31.
555 Differential expression of sarcolipin protein during muscle development and cardiac pathophysiology.J Mol Cell Cardiol. 2007 Aug;43(2):215-22. doi: 10.1016/j.yjmcc.2007.05.009. Epub 2007 May 18.
556 TIMD4 rs6882076 SNP Is Associated with Decreased Levels of Triglycerides and the Risk of Coronary Heart Disease and Ischemic Stroke.Int J Med Sci. 2019 Jun 2;16(6):864-871. doi: 10.7150/ijms.31729. eCollection 2019.
557 Left ventricular concentric remodelling and functional impairment in women with ischaemia with no obstructive coronary artery disease and intermediate coronary flow reserve: a report from the WISE-CVD study.Eur Heart J Cardiovasc Imaging. 2019 Aug 1;20(8):875-882. doi: 10.1093/ehjci/jez044.
558 Downregulation of linc00961 contributes to promote proliferation and inhibit apoptosis of vascular smooth muscle cell by sponging miR-367 in patients with coronary heart disease.Eur Rev Med Pharmacol Sci. 2019 Oct;23(19):8540-8550. doi: 10.26355/eurrev_201910_19168.
559 Cilostazol protects against myocardial ischemia and reperfusion injury by activating transcription factor EB (TFEB).Biotechnol Appl Biochem. 2019 Jul;66(4):555-563. doi: 10.1002/bab.1754. Epub 2019 May 1.
560 Association between genetic variations in TFR2 gene and coronary heart disease in Chinese: a case-control study.J Cardiovasc Med (Hagerstown). 2014 May;15(5):397-401. doi: 10.2459/JCM.0b013e32836206f3.
561 TREML4 mRNA Expression and Polymorphisms in Blood Leukocytes are Associated with Atherosclerotic Lesion Extension in Coronary Artery Disease.Sci Rep. 2019 May 10;9(1):7229. doi: 10.1038/s41598-019-43745-y.
562 TRIB1 and TRPS1 variants, GG and GE interactions on serum lipid levels, the risk of coronary heart disease and ischemic stroke.Sci Rep. 2019 Feb 20;9(1):2376. doi: 10.1038/s41598-019-38765-7.
563 A genetic variant near adaptor-related protein complex 2 alpha 2 subunit gene is associated with coronary artery disease in a Chinese population.BMC Cardiovasc Disord. 2018 Aug 7;18(1):161. doi: 10.1186/s12872-018-0905-2.
564 Role of CTRP3, CTRP9 and MCP-1 for the evaluation of T2DM associated coronary artery disease in Egyptian postmenopausal females.PLoS One. 2018 Dec 17;13(12):e0208038. doi: 10.1371/journal.pone.0208038. eCollection 2018.
565 Admixture Mapping of Subclinical Atherosclerosis and Subsequent Clinical Events Among African Americans in 2 Large Cohort Studies.Circ Cardiovasc Genet. 2017 Apr;10(2):e001569. doi: 10.1161/CIRCGENETICS.116.001569.
566 CRISPLD1 rs12115090 polymorphisms alters antiplatelet potency of clopidogrel in coronary artery disease patients in Chinese Han.Gene. 2018 Dec 15;678:226-232. doi: 10.1016/j.gene.2018.08.027. Epub 2018 Aug 7.
567 Biomarkers as predictors of sudden cardiac death in coronary artery disease patients with preserved left ventricular function (ARTEMIS study).PLoS One. 2018 Sep 18;13(9):e0203363. doi: 10.1371/journal.pone.0203363. eCollection 2018.
568 PPBP and DEFA1/DEFA3 genes in hyperlipidaemia as feasible synergistic inflammatory biomarkers for coronary heart disease.Lipids Health Dis. 2017 Apr 19;16(1):80. doi: 10.1186/s12944-017-0471-0.
569 Variant in GALNT3 Gene Linked with Reduced Coronary Artery Disease Risk in Chinese Population.DNA Cell Biol. 2017 Jul;36(7):529-534. doi: 10.1089/dna.2017.3688. Epub 2017 Apr 28.
570 Polymorphisms in the Glucagon-Like Peptide 1 Receptor (GLP-1R) Gene Are Associated with the Risk of Coronary Artery Disease in Chinese Han Patients with Type 2 Diabetes Mellitus: A Case-Control Study.J Diabetes Res. 2018 Sep 9;2018:1054192. doi: 10.1155/2018/1054192. eCollection 2018.
571 Expression of the Marburg I Single Nucleotide Polymorphism (MI-SNP) and the Marburg II Single Nucleotide Polymorphism (MII-SNP) of the Factor VII-Activating Protease (FSAP) Gene and Risk of Coronary Artery Disease (CAD): A Pilot Study in a Single Population.Med Sci Monit. 2018 Jun 21;24:4271-4278. doi: 10.12659/MSM.906984.
572 How much for a broken heart? Costs of cardiovascular disease in Colombia using a person-based approach.PLoS One. 2018 Dec 19;13(12):e0208513. doi: 10.1371/journal.pone.0208513. eCollection 2018.
573 A new promoter polymorphism in the gene of lipopolysaccharide receptor CD14 is associated with expired myocardial infarction in patients with low atherosclerotic risk profile.Arterioscler Thromb Vasc Biol. 1999 Apr;19(4):932-8. doi: 10.1161/01.atv.19.4.932.
574 Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease.Nat Genet. 2011 Mar 6;43(4):333-8. doi: 10.1038/ng.784.
575 Significant association of RNF213 p.R4810K, a moyamoya susceptibility variant, with coronary artery disease.PLoS One. 2017 Apr 17;12(4):e0175649. doi: 10.1371/journal.pone.0175649. eCollection 2017.
576 Vinexin Ablation Inhibits Atherosclerosis in Apolipoprotein E-Deficient Mice by Inactivating the Akt-Nuclear Factor B Inflammatory Axis.J Am Heart Assoc. 2017 Feb 16;6(2):e004585. doi: 10.1161/JAHA.116.004585.